Pituitary aplasia dysplasia and ectopic neurohypophysis …

Harvey B Sarnat MS MD FRCPC

Developmental Malformations

Updated 04.10.2024
Released 06.03.1997
Expires For CME 04.10.2027

Pituitary aplasia, dysplasia, and ectopic neurohypophysis

Author: Harvey B Sarnat MS MD FRCPC

See Contributor Disclosures

Pituitary aplasia, dysplasia, and ectopic neurohypophysis

In This Article

Quick Link

Introduction

Overview

Key points

	• Anterior pituitary aplasia or dysplasia is associated with endocrinopathies and often with malformations of the eyes, brain, or somatic anomalies; multiple genes are implicated, particularly LHX4, OTX2, and HESX1.
	• Ectopic neurohypophysis and posterior pituitary dysplasia is mainly associated with anterior pituitary endocrine defects because of early neural induction of the Rathke pouch; the HESX1 gene is mostly implicated.
	• Pituitary aplasia and dysplasias may occur as isolated anomalies or as part of major brain malformations, most frequently with septo-optic dysplasia, holoprosencephaly, and Joubert syndrome. Duplications of the pituitary also can occur.
	• Clinical manifestations largely are related to the endocrinopathies but also may involve intellectual deficits, visual problems, and olfactory impairment.
	• Diagnosis is based on clinical history, physical examination, endocrine function studies, and neuroimaging, particularly MRI.
	• Treatment addresses correction of endocrine deficiencies.
	• Growth hormone deficiency is the most frequent endocrinopathy of infancy, but other pituitary hormonal insufficiencies may appear later in childhood, so vigilant monitoring is recommended in follow-up.
	• Numerous genes are reported in isolated growth hormone deficiency, but most frequently due to GH1 and GHRHR mutations.

Historical note and terminology

Pituitary aplasia (absence) is a rare condition first described in the 1950s and 1960s (33; 187; 219). It has been related to ciliary gene mutations, exemplified in patients with type 9 oral-facial-digital syndrome (03).

Pituitary hypoplasia, in which the pituitary gland is diminutive and leads to congenital hypopituitarism, is not always an anatomical anomaly of the adeno- or neurohypophysis (anterior and posterior pituitary) identified in neuroimaging studies to correlate with functional neuroendocrine disorders. Ectopic (ie, displaced) neurohypophysis is a common anatomical anomaly, with or without other brain malformations.

The term pituitary dysplasia may be associated with abnormalities in the adenopituitary cells (104; 194; 135), abnormalities in the neuropituitary cells (140; 14), or other abnormalities in the tissue components that are vital for the organ. Ectopic adenopituitary tissue was found pharyngeally (158), and ectopic neuropituitary tissue has been described in cases where the neuropituitary gland is either absent or underdeveloped (11; 42).

The diagnoses of pituitary aplasia, hypoplasia, and dysplasia are difficult to make. In the diagnostic process, three principal methods are used: (1) endocrinological, (2) radiological, and (3) autopsy methods. In extremely preterm neonates, serum hormonal levels differ significantly from those of late preterm and full-term neonates; therefore, it is important that hospital laboratory has reference concentrations at different gestational ages of preterm infants (85).

The diagnosis of pituitary agenesis (the absence of pituitary gland primordium) can be made only after the pharyngeal side of the cranial base has been examined for adenopituitary tissue and the brain has been investigated for neuropituitary tissue by MRI or neuropathological examination.

The diagnosis of pituitary aplasia, in which no pituitary gland tissue is found where the gland is normally located in the sella turcica, necessitates a description of the morphology of the sella turcica. In abnormal sella turcica morphology, (such as that observed when a craniopharyngeal canal has formed in the floor of the sella turcica), glandular tissue may be found in the osseous canal (121; 125; 124). Similar precautions are necessary in order to make the diagnosis of hypoplasia and dysplasia. The nomenclature of pituitary abnormalities should take into account the complicated normal embryological origin of the gland (36). The sella turcica, a superior depression in the sphenoid bone, also has a complex embryology and is altered in size and shape with developmental structural defects of the pituitary (226).

In this review, the term “pituitary aplasia” will be used to refer to the condition observed when the pituitary gland is absent or where a rudimentary gland in a normally developed sella turcica is recorded. Accordingly, this condition does not include cases in which pituitary tissue is found in localities other than the sella turcica.

“Pituitary dysplasia” is understood to be all forms of defect in the organ caused by defective development, including malposition of pituitary tissue and ectopic neurohypophysis. The “pituitary stalk interruption syndrome” is characterized by a triad of interrupted pituitary stalk, absent or ectopic neurohypophysis, and anterior pituitary hypoplasias or aplasia, the latter often leading to panhypopituitarism; the diagnosis is confirmed by MRI (185; 239). This triad is really just a variant of the ectopic neurohypophysis syndrome.

Rarely, by contrast with agenesis, the pituitary may be duplicated (39; 81). Hyperplasia of the single midline pituitary may occur in hypothyroidism (245).

Clinical manifestations

Presentation and course

Congenital pituitary aplasia and dysplasia is a rare disorder occurring most often in combination with other midline craniofacial abnormalities like septo-optic aplasia, anencephaly, and holoprosencephaly (10). When associated with septo-optic dysplasia, other variable anomalies may be associated, including congenital oculomotor palsy (255) and anomalous cerebral vessels including anomalous origin of the anterior choroidal arteries, absence of the great vein of Galen, and right Rosenthal vein leading to the superior petrosal sinus (41). Neonates with septo-optic-pituitary dysplasia may show hypernatremia, hypoglycemia, and persistent hypothermia (23). Septo-optic-pituitary dysplasia is the most frequent cause of optic nerve hypoplasia, and most patients have hormonal deficiencies (237). Rarely, hypopituitarism also may include prolactinoma (184). The degree of optic nerve hypoplasia seen by MRI in septo-optic-pituitary dysplasia and severity of clinical visual impairment are not always concordant (198). Optic nerve hypoplasia is usually bilateral but may be asymmetrical or unilateral (166). Aplasia of the olfactory bulbs, tracts, and sulci occur in 8.6% of cases (198). Callosal agenesis or hypoplasia occurs in 15% of patients with septo-optic-pituitary dysplasia (166).

Panhypopituitarism is the general finding in pituitary aplasia and dysplasia (26; 164). Signs and symptoms of anterior hypopituitarism are almost always present, whereas posterior pituitary function may or may not be impaired. Accordingly, growth hormone is almost always deficient, whereas adrenocorticotropin and thyroid-stimulating hormone are deficient in a large proportion of patients. Clinical deficiencies of the other adenohypophyseal hormones are less common. The CHARGE syndrome may be associated with structural abnormalities of the pituitary and panhypopituitarism (86). Other rare associations of pituitary hypoplasia are with Rubinstein-Taybi syndrome, some patients of which also exhibit a novel cAMP-binding protein mutation (152).

Normally, several symptoms of hypopituitarism present early in the neonatal period. These include sluggishness, lethargy, cyanosis, shock, and other nonspecific symptoms presenting at birth or developing within hours thereafter. Severe hypoglycemia, frequently associated with seizures, is a key symptom that generally appears during the first day of life. Hypoglycemia is seen in 15% to 35% of the patients. Neonatal hyponatremia and persistent hypothermia may accompany the hypoglycemia (23).

Male infants show underdevelopment of the external genitalia in the form of microphallus, undescended testes, or underdeveloped scrotum, whereas the external genitalia of females are unaffected (114).

The disorder is often associated with hypoplastic thyroid and adrenal glands along with hypothyroidism and adrenocortical insufficiency. Hypothyroidism is not revealed clinically during the first days of life; therefore, the results of neonatal thyroid screening programs may be the first recognized sign of this endocrine malfunction. If undiagnosed, the adrenocortical insufficiency may be the cause of death (227).

Hypopituitarism in pituitary aplasia and dysplasia manifests earlier than in children with acquired pituitary lesions. Growth hormone is not essential for intrauterine growth, and the infants are of normal length and body weight at birth. Noticeable growth retardation is present at 12 months to 18 months of age and may be present as early as 3 to 6 months of age. The body proportions are normal (70). The patients tend to be obese. The patients’ height age is less than their weight age. The excess fat is frequently concentrated over the chest and abdomen. Delayed tooth eruption and round face are usually found. Neurodevelopment (cognitive, psychosocial, and language skills) is generally delayed in untreated children; however, this is much less so when children are diagnosed early and appropriately treated.

Coupled with the endocrinological manifestations are manifestations of impaired skeletal development. Skull x-ray, CT scans, and MRI scans may reveal an empty sella or a craniopharyngeal canal (88).

An association of hypopituitarism and unilateral agenesis or hypoplasia of the internal carotid artery was reported (137; 200). The genetic basis is unknown but is not due to mutations of the HESX1, LHX4, or OTX2 genes (137).

Hyperbilirubinemia and prolonged icterus, along with hepatitis-like histological hepatic changes, have been reported (93; 89).

Hypothalamic-pituitary dysfunction secondary to dysgenesis may result in psychiatric symptoms, particularly depression and even suicide in adolescents (30; 145; 161).

A solitary median central incisor may be a useful clinical biomarker of hypoplastic anterior pituitary and ectopic neurohypophysis and is associated with holoprosencephaly or septo-optic-pituitary dysplasia, so the teeth should be observed during physical examination (60).

Biological basis

Etiology and pathogenesis

The cause of pituitary aplasia and dysplasia is a genetic defect that causes an early embryological developmental defect in the hypophyseal placode or in the processes that initiate the transformation of the placode into the hypophyseal organ. The suggestion has been posited claiming that the notochord is decisive in this developmental process (125).

Normal ontogenesis. The embryology of pituitary development is that the adenohypophysis develops from the outpouching of ectoderm at the roof of the oral cavity (Rathke pouch) and neurohypophysis, infundibulum, and pituitary stalk from the neuroectodermal floor of the diencephalon (97; 199; 06). The primordium of the adenohypophysis can be distinguished in the human embryo as early as 22 days gestation (63), and the HESX1 gene is implicated in this development (50). Five different cell types secreting six different hormones all arise from a common progenitor; morphogenesis involves complex regulatory networks with transcription factors and both intrinsic and extrinsic signaling molecules (06). Both neural crest cells and endoderm-lineage cells invade the primordial developing pituitary and contribute in the adult to maintenance and perhaps to neoplasia (111).

Rathke pouch invaginates upward from the oral cavity toward the ventral diencephalon at about 28 days, eventually making direct contact with the diencephalon in the midline, separated from it only by a thin intervening basement membrane as it elongates (218). The anatomical development of the pituitary is complete by 49 days and is followed by functional specialization and differentiation of the various hormonal secretory cells with formation of the portal circulation; reciprocal inductive signals between the diencephalon and Rathke pouch affect growth hormone (84). The growth hormonal deficiency in ectopic neurohypophysis can, thus, be explained, even though growth hormone is of adenohypophysial origin. Persistence of the craniopharyngeal canal occurs with ectopic neurohypophysis secondary to SOX3 gene deletions in both the mouse and in humans (05). Persistent expression of activated Notch in the developing hypothalamus affects survival of pituitary progenitor cells and alters pituitary structure but the importance of Notch in the pathogenesis of most cases of human ectopic neurohypophysis is uncertain (13). An important gene with an essential role in hypothalamic neuronal lineages in the mouse is Orthopedia (Otp), which is expressed in various nuclei, including the anterior periventricular, paraventricular, and supraoptic (240). Rare cases of infundibular aplasia associated with ectopic neurohypophysis are described, but the genetic basis is not yet established (244). Some cases with extensive telencephalic and diencephalic malformations are attributed to a neuroblast migratory disorder (171) but the mechanisms of pathogenesis are multiple in these cases and neuroblast migration is only one of several impaired developmental processes. Normal hypothalamopituitary development is closely related to that of the forebrain and depends on complex genetic cascades of transcription factors and signaling molecules either intrinsic or extrinsic to Rathke’s pouch (115).

Abnormal ontogenesis. The normal embryological development of the pituitary gland is disturbed in pituitary aplasia and dysplasia (17). The embryonic region, from which the pituitary gland arises, can (analogously to the nasal, lens, and otic placodes) be termed the “pituitary placode.” All four placodes exhibit the same structural stratification in the placode region, characterized by direct adherence of surface ectoderm to neuroectoderm. This basic connection does not disappear during subsequent normal development. In the pituitary gland, this adherence occurs throughout life at the site where the intermediate part (derived from surface ectoderm) adheres to the neuropituitary gland (derived from neuroectoderm) (127). This concept of pituitary development by sustained placode adherence differs from that proposed earlier, in which an invagination of surface ectoderm gradually extended cranially and finally fused with the infundibulum. During development, the surface ectoderm and neuroectoderm both form process-like extensions (Rathke pouch and the infundibulum, respectively). These anatomic structures are presumed to arise by mesodermal "filling up" of parachordal tissue and neural crest cells around the persisting placodal contact. This means that the surface ectoderm is drawn out of the pharyngeal mucosa, from where it disrupts, and the neuroectoderm is drawn out in an infundibular process of the diencephalon. Transcription factor 7-like 1 (TCF7L1) is involved in hypothalamo-pituitary axis development in both mice and humans, particularly for induction and subsequent expansion of Rathke pouch progenitors; its deficiency results in pituitary aplasia and sometimes forebrain anomalies (78).

After these changes in the surrounding mesoderm, the sella turcica develops, first in cartilage and then in bony tissue (123). Once the sella turcica has formed, the connection through the cranial base is severed, and the boundary between the posterior notochordally derived cranial base and the anterior (mainly neural crest-derived) cranial base can no longer be distinguished in the sella turcica. The pathogenesis and pathophysiology for maldevelopment of the pituitary gland may accordingly be molecular biological defects in (1) the surface ectoderm or in adhesions in the placode region, (2) defects in parachordal mesodermal penetration (so-called "filling up"), and (3) defects in neuroectodermal development.

Central nervous system and surrounding axial skeleton in human fetus

The central nervous system (yellow) and the surrounding axial skeleton in a human fetus (17 weeks' gestation). The notochord (red) is surrounded by the spine, the basilar part of the occipital bone, and the postsphenoid part of th...
Human embryo (photomicrograph)

Histological sagittal section of a human embryo, gestational age 7 weeks. Anterior direction is left. The notochord appears in the cervical bodies and in a zigzag course in the cranial base, ending rostrally close to the developin...
Sella turcica region and pituitary gland from normal fetus

Left schematic drawing and right histological sagittal section of the sella turcica region and the pituitary gland from a normal human fetus, gestational age 16 weeks. Anterior direction is left. The adenopituitary gland appears d...

In holoprosencephaly, an antenotochordally located defect is seen in the surface ectoderm, mesoderm, and neuroectoderm (210; 199). The developmental defect extends in the horizontal plane in a fanlike shape from the pituitary gland to the eyes and in the frontal plane in a fanlike shape from the premaxilla to the eyes (128; 124). This hereditary condition often may be attributable to the Sonic Hedgehog gene (191). In holoprosencephaly, a dysplastic development of the pituitary gland occurs with malposition of the adenohypophyseal tissue and malformation of the sella turcica (62; 121; 37; 155).

Tissue block from sella turcica in holoprosencephalic cyclopic fetus

Left schematic drawing and right histological sagittal paraffin section of a tissue block from the sella turcica region in a human holoprosencephalic cyclopic fetus, gestational age 16 weeks. Anterior direction is left. Note the c...

In nasal placode malformation, in which the nasal cavity does not form, hypophyseal malformation can likewise be seen, resulting in no pituitary gland primordium in the sella turcica region but with the entire adenohypophysis located in the pharynx (131). In such cases, there has probably been defective adhesion between surface ectoderm and neuroectoderm. The reason for this is not known. Earlier studies have highlighted the fact that hypopituitarism or hypothalamic dysfunction occur in malformations other than holoprosencephaly and nasal placode malformation. These malformations include septo-optic dysplasia, midfacial anomalies (eg, hypertelorism), cleft lip and palate, Rieger syndrome, Pallister-Hall syndrome, and solitary maxillary central incisor (68; 186; 144; 193; 64; 90; 220; 100; 118; 45; 151; 163; 192; 136; 211).

Defects in parachordal mesodermal tissue penetration and in neuroectodermal development may be the cause of pituitary dysplasia as seen in anencephaly, where the neurohypophysis is often absent and where a craniopharyngeal canal is seen in the floor of the sella turcica. The same etiology may be behind transsphenoidal encephalocele, where pituitary aplasia is observed (122). These types of malformation may be related to notochord malfunction.

Tissue block in fetus with hypertelorism

Left schematic drawing and right histological sagittal paraffin section of a tissue block from the sella turcica region in a human fetus with hypertelorism and nasal malformation. Anterior direction is left. Note the absence of a ...

In spina bifida, ascribed to deviations in the Sonic Hedgehog gene expression (16), pituitary dysplasia is observed (126).

Midsagittal block from sella turcica in anencephalic fetus

Left schematic drawing and right histological sagittal paraffin section of a midsagittal block from the sella turcica region in a human anencephalic fetus, gestational age 20 weeks. Anterior direction is left. Note the craniophary...

Consequently, the pathogenesis and pathophysiology for pituitary aplasia and dysplasia shows that the sella turcica is a boundary region between the antenotochordal developmental field and the notochordal developmental field (121).

Midsagittal tissue block in fetus with spina bifida

Left schematic drawing and right histological sagittal paraffin section of a midsagittal tissue block from the sella turcica region in a human fetus with spina bifida in the lumbosacral region, 19 weeks of gestation. Anterior dire...

It is now possible to create in vitro pituitary organoids as experimental models (108).

Genetic bases and correlates. Animal data indicate that the pit-1 gene is necessary for the specification of the phenotype of the three cell types of the anterior pituitary gland (142). Mutations in the pit-1 gene have been demonstrated in children with combined pituitary hormone deficiency (169; 183; 72). A novel pituitary paired-like homeodomain factor, appearing to be an important prerequisite for the expression of the transcription factor pit-1, is named prophet of pit-1 (59). In a review, Westphal summarized the genes that fashion the pituitary gland in the following way (243):

One of the first gene products involved in early pituitary organogenesis is BMP4, a member of the TGF [beta] family of secreted signaling molecules. BMP4 is expressed in the neural ectoderm of the infundibulum. Thereafter, the infundibulum releases FGF8. FGF10 and BMP2 are additional secreted molecules that have been implicated in the process of forming the Anlage of the pituitary gland. These pituitary-specific patterns are initiated by two members of the LIM-homeobox gene family of transcription factors, termed Lhx3 and Lhx4. The next stage of pituitary development is characterized by the activity of control genes Pitx1 and Pitx2. This period of precursor expansion appears to be controlled by Rpx/Hesx1, a member of the paired-like family of homeobox genes. The formation of the hormone-secreting pituitary gland is heralded by the emergence of Prop1, another member of the paired-like family of homeobox genes. Prop1 activity is needed for the expression of Pit1. Early cell-to-cell signaling, mediated by secreted morphogens, results in the definition of organ rudiments.

Sbrogna and colleagues suggest that “Hh signaling from neural ectoderm is necessary for induction and functional patterning of the vertebrate pituitary gland” (202). Ectopic hypophysis or pituitary stalk interruption syndrome is characterized by genetic heterogeneity as demonstrated by whole-exome sequencing including rare and novel variant genes (32; 212).

Over the last few years there has been an increasing clinical interest in correlating genetic abnormalities with the phenotypic appearance. Initially, this correlation began in patients with Pit-1 mutations, but other genes have been analyzed and a large number is now implicated (82). An example is a study of a family with an LHX4 germline splice-site mutation resulting in short stature and pituitary and hindbrain defects in combination with abnormalities in the skull base (148). Other authors do not find a strong correlation between posterior pituitary deficiency in particular and LHX2 mutations (174). Absence of the anterior pituitary with panhypopituitarism and ectopic neurohypophysis is seen in 1p31.1-1p31.3 microdeletion (228). Mutations in the BMP4 gene cause pituitary insufficiency associated with anophthalmia and polysyndactyly (213). The OTX2 gene also is implicated in some cases of pituitary dysgenesis with hormonal deficiencies associated with pineal, ocular, and ear defects (79; 213). PAX6 mutation may impair pituitary function, but aniridia or anophthalmia are more frequent expressions (209). Similar ocular anomalies with hypopituitarism and other anomalies are associated with ARNT2, SOX2, and OTX2 mutations (242; 147). Other genes involved as transcription factors in pituitary development are PROP1, POUF1, LHX3, and LHX4, but mutations of these genes have not been shown to cause pituitary aplasia (145). Optic nerve hypoplasia, a component of septo-optic-pituitary dysplasia (DuMorsier syndrome), does not necessarily predict the hypopituitarism that occurs in many but not all young patients (76), but all children presenting with optic nerve hypoplasia should be evaluated for neuroendocrine deficiency and by MRI for midline brain malformation (133). A large number of genetic mutations have been demonstrated in Kallmann syndrome and hypogonadotropic hypogonadism (80; 234). Biallelic mutation in the gene EXOC3L2 causes a rare syndrome affecting the brain with visual impairment, pituitary hypoplasia with hormonal deficiencies, and kidneys and blood; the mechanism involves trafficking of post-Golgi vesicles to the plasma membrane (206). SEMA3A mutation at 7q21 locus (a gene involved in hypothalamic neuroblast migration) causes short stature and multiple pituitary hormonal deficiencies that may not be recognized until adult life in some cases and also can be associated with dysplasias of heart, kidney, and long bones (96). An epigenetic phenomenon by prenatal alcohol exposure in mice copies Cdon mutation by impeding Shh function and is another etiology of optic nerve hypoplasia and may be relevant to human fetal alcohol spectrum disorder (106).

Mitchell and colleagues stated that “HESX1 is the only gene associated with ectopic posterior pituitary lobe” (162) and other authors have confirmed this HESX1 mutation with ectopic neurohypophysis (229), in a large series of 83 patients (189), and in a familial pedigree with consanguineous parents; the phenotype is variable with the same HESX1 genotype, even amongst siblings in the same family (67). Ectopic neurohypophysis may be associated with extrapituitary cerebral malformations but is more frequently an isolated finding (28). In sum, it is now evident that no single gene can account for all of the anterior pituitary aplasias and dysplasias and the extreme variability in associated brain, eye, and somatic abnormalities, but posterior pituitary ectopia or dysplasias may be due to a single or more limited number of mutated genes.

Isolated growth hormone deficiency is usually due to GH1 and GHRHR mutations, but numerous other novel mutations have also been demonstrated in isolated cases associated with under stature (241). Similarly, there are many new genes identified in cases of central congenital hypothyroidism, but they are different genes from those of growth hormone deficiency (204). Some antiepileptic medications may affect thyroid hormonal function as an epigenetic phenomenon (91), and some pregnant women who have epilepsy require medication during pregnancy and, thus, the fetus may be affected. Pituitary thyroid-stimulating hormone may remain normal in some.

Documentation states that mice lacking the homeobox gene Hesx1 exhibit variable anterior CNS defects (48). These comprise a reduced prosencephalon, abnormalities in the corpus callosum and septum pellucidum, anophthalmia or microphthalmia, defective olfactory development, and pituitary dysplasia. Septo-optic dysplasia is a comparable and highly variable phenotype in humans (49). HESX1 mutations were associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia in 228 patients (229). The association of septo-optic-dysplasia with pituitary aplasia and ectopic neurohypophysis is so well documented that this malformation is now generally called “septo-optic-pituitary dysplasia,” though not all cases include pituitary defects (154; 205; 141; 231). Aplasia of the neurohypophysis has even been demonstrated at autopsy in a fetus of 23 weeks gestation (103). It also may be seen in some cases of holoprosencephaly (155). A novel homozygous HESX1 mutation, however, can cause isolated panhypopituitarism without midline defects or optic nerve hypoplasia (58).

Another important mutation associated with ectopic neurohypophysis, growth hormone deficiency, or panhypopituitarism is OTX2, often with a microdeletion at locus 14q22.3 and consisting of either frameshift or nonsense mutations (105; 143; 208). The endocrinopathy is often easy to suspect in this genetic defect because of the phenotype clinical markers in involved patients: anophthalmia or microphthalmia, at times agenesis of the left carotid artery, and intellectual deficits.

A small supernumerary marker chromosome resulting in a tetrasomy 22pter-22q11.21 is the characteristic genetic mutation in the cat eye syndrome, often with Mendelian transmission, hence, familial cases (102). Malformation of the hypothalamic-pituitary axis and growth hormone deficiency are demonstrated in affected children, as well as ocular iris configuration with a dorsoventrally elongated pupil resembling felines.

Quentien and colleagues found that “the transcription factor Pitx2 is required for the morphogenesis of anterior structures such as the eye, teeth, and anterior pituitary” (182). As “Pit3 gene belongs to the family of RIEG/PITX genes…it is transcribed in the presumptive pituitary already at the open neural tube stage. During further development Xpitx3 is strongly transcribed in the pituitary Anlage, the lens placodes and head mesenchyme, respectively” (178).

Pituitary dysfunction or hypoplasias may be associated with the Fanconi anemia syndrome (107). In children with congenital melanocytic nevi, including neurocutaneous melanocytosis (a postzygotic mosaic RASopathy), the pituitary may be abnormal structurally and functionally, particularly with respect to growth hormone and to insulin insensitivity (238).

Chromosomopathies associated with pituitary dysplasia and insufficiency include 1q24.3q31.1 deletion in a girl who also had congenital lipomatosis of the face (35; 241), but chromosomal deletions, duplications, or translocations generally are rare in this disorder. Ring chromosome-18p deletion, however, results in anterior pituitary aplasia, with its resulting multiple neuroendocrinopathies (21). The male newborn of a mother with Turner syndrome (45X0) had severe panhypopituitarism and anatomical pituitary stalk interruption syndrome (ectopic neurophypophysis) and a normal 46XY karyotype; most women with Turner syndrome are infertile, but 2% to 8% can become pregnant (170).

Little is known about the influence of the genotype on the pituitary gland morphology and on the appearance of the sella turcica. The first systematic prenatal study is a study of the region in 14 human trisomy 18 fetuses (129). In all of the fetuses, pituitary dysplasia occurred with pharyngeally located adenopituitary tissue and malformation of the sella turcica. The pharyngeal tissue showed a positive reaction to immunohistochemical marking for thyroid-stimulating hormone. Postnatally, Taine and colleagues found pituitary dysplasia in a girl with an 18p deletion, total growth hormone deficiency, and a single central maxillary incisor (223). In a study on sella turcica pituitary gland development in prenatal trisomi-21, four different morphological types were described (130). The appearance of the most frequently occurring morphological type resembled normal appearance (type I).

Sella turcica region from a human trisomy 18 fetus

Sagittal section of a sella turcica region from a human trisomy 18 fetus, 19 weeks of gestation. Anterior direction is left. (A) toluidine blue; (B) immunohistochemical reaction to thyroid-stimulating hormone. Adenopituitary tissu...

To further elucidate the influence of the genotype on the phenotypic development in the pituitary gland region, prenatal and postnatal charting of the malformation fields in different genotypes, either histologically (157; 24; 125) or by CT or MRI scanning (mapping sella turcica morphology and the possible presence of a craniopharyngeal canal) (132), are important. Abnormal morphology of craniofacial tissues including the adenohypophysis has been described in a fetus with hypohidrotic ectodermal dysplasia (168). Animal studies generally correlate well with human data. The transcription factor of insulin gene-enhancing protein isl2a is a regulatory factor in pituitary development and subsequent function in zebrafish (246).

Duplication of the pituitary stalk and hypophysis. This rare malformation is probably due to upregulation of a ventralizing gene. It can be associated with other midline cerebral defects, precocious puberty, and 2p12 deletion (179). It is also reported in association with nasopharyngeal teratoma, hypothalamic hamartoma, and cleft palate (39) or with benign nasal hamartoma (81). It also is described with pituitary adenoma and aqueductal stenosis, and with vertebral anomalies (175; 159). Association with heterozygous deletion of chromosome 14, in which the gene encoding thyroid transcription factor-1 is localized, is yet another different condition (02). ROBO1 deletion is associated with pituitary stalk interruption (ectopic neurohypophysis) but also duplication; this gene is known to be involved in neurogenesis and axonal guidance (203). In sum, the duplication of the pituitary stalk is probably multifactorial and due to multiple genetic defects, unlike ectopic neurohypophysis. A rare hereditary pituitary hyperplasia without stalk duplication also is described with infantile gigantism (83). Rathke cleft cysts are associated with pituitary dysplasia and particular involvement of gonadotropic hormones, especially in pubertal girls who showed estrogen receptor immunoreactivity in pituitary cells but not in the cells lining the cyst (110).

Ectopic neurohypophysis. This term refers to an interrupted or greatly thinned pituitary stalk with ventral displacement of the posterior pituitary. The diagnosis is based on MRI findings. Neuropathological examination to confirm the status of the pituitary stalk is rare because treatment is nonsurgical and autopsy findings are not well documented in this regard and are prone to artifactual disruption even if considered before brain removal. Gender and ethnic predispositions to ectopic neurohypophysis are not noted. An incomplete or partial form of ectopic posterior hypophysis is recognized by MRI (08).

The first recorded description of ectopic neurohypophysis was a neuropathological study in 1927 by Priesel (180). The entity was then essentially forgotten for many decades and rediscovered in the era of MRI by Fujisawa and colleagues in a 1987 paper (73). An ectopic or ventrally displaced posterior pituitary gland was then reconfirmed on MRI by numerous subsequent authors (113; 116; 01; 149; 12; 34; 232; 176; 92; 134; 40; 162; 251; 250; 224; 235; 99; 150; 196; 249; 236). It is most readily recognized by the intense unenhanced T1-weighted signal of the neurohypophysis normally seen in MRI at the median eminence in the floor of the 3rd ventricle, but which also can disclose an ectopic location. The increased T1 signal is attributed to neurosecretory vesicles, more specifically an enhanced relaxation of water protons adjacent to these vesicles (31; 251). The T1 signal is enhanced by gadolinium.

Neurohypophysis (normal)

Sagittal spin-echo T1-weighted image of a 3-week-old term infant demonstrates normal pituitary stalk, anterior pituitary lobe, and posterior pituitary lobe (arrow). The slice thickness is 5 mm with an interslice gap of 1 mm. The n...
Ectopic neurohypophysis in infant

Ectopic neurohypophysis in a 3-week-old female with congenital hypopituitarism. (A) On sagittal spin-echo T1-weighted image (thickness/gap: 5/0 mm), a round focus of hyperintense signal (arrow) is seen at the anterior floor of the...
Ectopic neurohypophysis in neonate

MRI, T1 in sagittal plane, of ectopic neurohypophysis in 3-day old neonate born at 37 weeks by caesarean section. This lesion was not identified in a fetal MRI performed at 25 weeks’ gestation. This infant also has bilateral periv...

More than 90% of publications on the topic are found in the radiology literature, with additional publications in genetics and endocrinology journals, but almost none are found in the neurologic literature.

Neurologic manifestations of ectopic neurohypophysis. The clinical expression depends largely on the other associated cerebral malformations and may be epilepsy, cognitive and intellectual deficits, and motor deficits such as pseudobulbar palsy and spastic diparesis. Endocrinologic manifestations are usually an isolated growth hormone deficiency, and this may lead chronically to short stature or dwarfism if not recognized early and treated with exogenous growth hormone (232; 40). In adolescent or young adult girls, short stature and amenorrhea may be presenting symptoms (254). Multiple defects of the hypothalamic-pituitary axis with panhypopituitarism also may occur (40; 185). Abnormal ADH secretion and diabetes insipidus, as might be expected with posterior pituitary defects, is rare or absent. Neuroimaging demonstration of ectopic neurohypophysis can be correlated the presence of growth hormone deficiency (53). Hypopituitarism associated with ectopic neurohypophysis may complicate some cases of static encephalopathies with spastic diplegia (ie, cerebral palsy); therefore, at least a limited endocrine panel should be included in the investigation of such children (233). Hypopituitarism discovered in young adult life may occur and lead to imaging confirmation of ectopic neurohypophysis (253). Ectopic neurohypophysis is associated in some cases with developmental brain malformations, including perisylvian polymicrogyria and cerebellar dysplasia (230). Joubert syndrome of cerebellar and brainstem anomalies (221), and also suprasellar arachnoidal cysts (201). Renal anomalies also are reported in some cases of ectopic neurohypophysis, so renal status should be assessed (172). Poland syndrome (absence of pectoralis major muscle) can be accompanied by ectopic neurohypophysis, associated with a 1.5Mb Xp22.31 duplication (153).

Etiology and pathogenesis of ectopic neurohypophysis. The most common predisposing factor in the etiology of ectopic neurohypophysis is believed to be genetic, and familial cases are well documented (113; 01; 149; 12; 232; 176; 92; 134; 40; 189). Mutated genes in a minority of cases are HESX1 (229) and LHX4 (224). HESX1 is a gene implicated in septo-optic-pituitary dysplasia, a malformation in which ectopic neurohypophysis is a frequent component, and HESX1 in addition is essential for pituitary development in the embryo. A novel nonsense mutation of the GLI2 gene also is reported (71). Other genetic mutations associated with ectopic neurohypophysis include SOX3 (Xq26.3-27.3) (05; 216), GPR161 in a family identified by whole-exome sequencing (109), ROBO1 (19; 203), digenic PROKR2 and WDR 11 (156), a lethal autosomal recessive LHX4 (87), and in 18p deletion (247). It is also reported in Turner syndrome (45XO) (61). The ciliopathy TTC26 due to a homozygous mutation can produce this pituitary phenotype (51). A genetic cause is, thus, likely. The original etiological explanation of traumatic transaction of the pituitary stalk at birth, particularly with breech delivery, is no longer tenable. Many infants with ectopic neurohypophysis are born by vertex vaginal delivery or even by Caesarian section. Birth trauma also would not explain the association with other malformations of the brain.

Clinical vignette.

Ectopic neurohypophysis in infant

Ectopic neurohypophysis in a 3-week-old female with congenital hypopituitarism. (A) On sagittal spin-echo T1-weighted image (thickness/gap: 5/0 mm), a round focus of hyperintense signal (arrow) is seen at the anterior floor of the...
Ectopic neurohypophysis in neonate

MRI, T1 in sagittal plane, of ectopic neurohypophysis in 3-day old neonate born at 37 weeks by caesarean section. This lesion was not identified in a fetal MRI performed at 25 weeks’ gestation. This infant also has bilateral periv...

Ectopic adenohypophysis. Although ectopic neurohypophysis is common (see below), ectopic adenohypophysis is rare but is reported in the nasopharynx as a thyroid-stimulating hormone (TSH) secreting lesion (120).

Epidemiology

The incidence of pituitary aplasia and dysplasia is unknown. It would be important in the future to specify the incidences within the different types of malformation where pituitary aplasia and dysplasia occur and the inheritance within the individual types (195; 25). Subsequent studies with modern neuroimaging suggest that the incidence is much higher than has been appreciated (173). The MRI findings that have led to this recognition not only are visualization of the pituitary itself but increased recognition of the extracerebral malformations in septo-optic-pituitary dysplasia that account for a majority of cases (133; 77; 181), and specific genetic mutations are now being recognized, such as FEVR and FLNA (69; 252). Anterior pituitary atrophy also can be associated with Rathke cleft cyst, craniopharyngioma, local pituitary fossa arachnoidal cysts, and other anatomical lesions (74; 245). Patients with pituitary stalk interruption syndrome (ectopic neurohypophysis) are divided in syndromic (associated with other extra-pituitary brain malformations; 48%) and nonsyndromic (isolated) forms, with the syndromic showing the most severe anatomical and hormonal alterations (18).

Geographical distributions are sometimes noted: there is increased incidence of septo-optic-pituitary dysplasia in northern Canadian territories where the population is mainly indigenous and poverty, poor nutrition, and health issues are widespread; these exogenous conditions affect pregnant mothers and fetuses living in these regions (119). Another epidemiological focus worldwide is maternal age; in a large pan-European EUROCAT study the prevalence of septo-optic-pituitary dysplasia was found to be between 1.9 and 2.5 per 100,000 live births, with highest prevalence in those born to mothers aged 20 to 24 years (77). This prevalence in young mothers contrasts with most disorders in which older maternal age is a risk factor.

Differential diagnosis

In a 9-month-old male infant with sacral agenesis and caudal regression syndrome who also had growth hormone deficiency, endocrine replacement therapy had the additional beneficial effect of promoting distal muscle innervation of the lower extremities (56). A novel pathogenic variant in OFD1 results in X-linked Joubert syndrome, a ciliopathy, with orofaciodigital features and pituitary aplasia (09). Pituitary stalk interruption may occur in TTC26 mutation, another ciliopathy (51).

Clinically, the postnatal diagnosis of pituitary aplasia and hypoplasia is based on endocrinological charting, blood-glucose measurement, radiography, and CT or MRI scanning of the sella turcica region. The postnatal and prenatal autopsy diagnosis is based mainly on histological examination of the brain and the sagittal cranial base block, including the pituitary gland.

Hormonal deficiencies involving hypofunction of the hypothalamus or the anterior or posterior portion of the pituitary gland may be found in conditions other than pituitary aplasia and dysplasia. Conditions where the target organ is malfunctioning (eg, myxedema) or the target receptors are defective (eg, Laron syndrome) (defective growth hormone receptors) mimic hypofunction of the specific pituitary hormone. These conditions, however, are usually limited to one pituitary axis, making for an easier distinction. Some of the target organ failures may further be distinguished from the corresponding pituitary function by specific signs and symptoms (eg, the hyperpigmentation in Addison disease,) that are absent in hypopituitarism.

Neonatal hypoglycemia in pituitary aplasia and dysplasia may present with signs and symptoms similar to ketotic hypoglycemia (ie, severe hypoglycemia with ketonuria between meals). The conditions may be differentiated by the adrenocorticotropin, cortisol, and growth hormone deficiency present in the former. Furthermore, ketotic hypoglycemia tends to present later in life (18 months to 5 years).

For the purpose of CT or MRI differential diagnosis, it is important to be aware of the "empty sella" syndrome. Empty sella is not a disease but an anatomical state with characteristic radiological findings caused by many different pathological conditions requiring correct interpretation on each occasion (215). Empty sella is the radiological appearance of a sella turcica that is partially or completely filled with cerebrospinal fluid. Empty sella is common in adults, with a prevalence rate from autopsy of approximately 6% (44). The term "empty sella syndrome" should be used when an empty sella is present in association with headaches, visual disturbances, papilledema, or endocrine dysfunction. The precise etiology of empty sella is not known. Empty sella syndrome is rare in pediatric patients as compared to adults (256). However, approximately one-half of the children with growth hormone deficiency have a primary empty sella (222; 177). In a review of 175 adults with empty sella syndrome, endocrinopathy due to pituitary insufficiency was found in two thirds of cases, with a strong male predominance (88).

Rathke cleft cysts typically appear cystic with T1 hyperintensity and variable T2 signal and thin or no marginal enhancement, remaining stable over time (74). Persistence of the craniopharyngeal canal occurs with ectopic neurohypophysis secondary to SOX3 gene deletions in both the mouse and human (05). Persistent expression of activated Notch in the developing hypothalamus affects survival of pituitary progenitor cells and alters pituitary structure (13). In rare instances, large pituitary colloidal cysts may occur (75). Epidermoidal cysts of the isolated pituitary stalk have also been reported and can be successfully surgically resected (139).

McCune-Albright syndrome is a triad of polyostotic fibrous dysplasia of bone, precocious puberty, and cutaneous café-au-lait spots, but many cases later develop multiple endocrinopathies, particularly excessive growth hormone secretion (54; 248). Another bony dysplasia, Desbuquois dysplasia type 2, can be associated with growth hormone deficiency and XYLT1 mutations (101).

Ectopic prolactin-producing pituitary adenoma is reported rarely within a benign ovarian cyst teratoma (07). Congenital pituitary hypoplasia with hypopituitarism from birth may be associated with agenesis of the internal carotid artery (98).

Traumatic brain injury may follow closed head trauma in early childhood and may result in pituitary dysfunction and hormonal abnormalities, including precocious puberty, which should be treated and distinguished from congenital dysplasias of the pituitary or genetic defects affecting pituitary function (55; 214).

Diagnostic workup

When pituitary aplasia and dysplasia is suspected, revealing pituitary dysfunction by measurements of pituitary and target organ hormone levels is a key procedure in establishing the diagnosis. Demonstration of abnormally low growth hormone level is cardinal. Funduscopic examination should be performed by an ophthalmologist in all cases, not only for associated optic nerve hypoplasia but also for more subtle findings such as optic disc pits in ectopic neurohypophysis (95).

Growth hormone is released episodically, and random plasma levels in normal subjects are low, often at the level of detectability. A range of provocative tests that increase the plasma levels of growth hormone has been established. The drugs administered to provoke growth hormone release are L-dopa, clonidine, glucagon, insulin, or arginine. Growth hormone peak levels below 7 ng/mL during testing suggest growth hormone deficiency. Two or more of these tests must be positive in order to consider the patient to be growth hormone deficient.

The spontaneous levels of growth hormone may be evaluated in a 24-hour test. During the 24-hour test period, blood is drawn every 20 minutes to 30 minutes, and height and frequency of the plasma growth hormone peaks are evaluated. This type of procedure may enable the diagnosis in children with abnormal pulsatile function of growth hormone release. However, in children with an absence of growth hormone secretion, this test is usually not a necessary part of the diagnostic workup.

The plasma levels of insulin-like growth factor 1 reflect those of growth hormone and may be used to indicate growth hormone deficiency. In healthy children, levels of insulin-like growth factor 1 gradually increase from birth and peak at puberty. In growth hormone-deficient children, levels of insulin-like growth factor 1 are initially low but rise within 16 hours to 28 hours of growth hormone administration.

The finding of hypofunction of the pituitary-thyroid axis in the neonatal thyroid screening programs may be the first sign of pituitary aplasia or dysplasia. Levels of several pituitary hormones along with the target hormone plasma levels should be determined. Thus, full workup includes measurement of plasma thyroid-stimulating hormone, liothyronine, thyroxine, corticotropin, cortisol, follicle-stimulating hormone, luteinizing hormone, sex steroids, prolactin, and antidiuretic hormone. Interpretation of these results allows for differentiation between target organ failure and pituitary or hypothalamic failure. However, these tests may not allow for a differentiation between pituitary and hypothalamic failure.

Congenital hypopituitarism could be due to hypothalamic failure (15); thus, tests that bypass the hypothalamus should be performed to establish the diagnosis of pituitary aplasia or dysplasia. One such test is the combined anterior pituitary test that involves simultaneous intravenous administration of four releasing hormones: (1) growth hormone-releasing hormone, (2) corticotropin-releasing hormone, (3) luteinizing hormone-releasing hormone, and (4) thyrotropin-releasing hormone. The plasma levels of the pituitary hormones are measured. In addition to the relevance of the combined anterior pituitary test in evaluating the target hormone plasma levels, it may be used to screen patients with suspected pituitary dysfunction. Central hypothyroidism is another expression, including in septo-optic-pituitary dysplasia, readily treatable with replacement exogenous hormone (22).

Pituitary aplasia and dysplasia may present as moderate to severe hypoglycemia with ketonuria with missed meals. Spontaneous blood glucose levels from 9 mg/dL (0.5 mM) and greater have been reported. Cortisol or growth hormone deficiency may be the cause of hypoglycemia due to decreased gluconeogenic enzymes in cortisol deficiency, increased glucose utilization with lack of antagonistic effects of growth hormone on insulin action, or failure to supply endogenous gluconeogenic substrates with compensatory breakdown of fat and generation of ketones. In this manner, hypoglycemia in pituitary aplasia and dysplasia presents similarly to ketotic hypoglycemia.

Diagnostic imaging. MRI is essential to demonstrate pituitary anomalies and other brain malformations, including optic nerve hypoplasia and agenesis of the septum pellucidum (47; 165; 245; 181; 46; 38; 197). MRI is a good predictor of the severity and type of growth hormone deficiency in children (207). Associated disorders of neuroblast migration and the absence of olfactory bulbs, tracts, and sulci in 8.6% of cases also are revealed (197). Ectopic neurohypophysis (pituitary stalk interruption) and other anatomical pituitary anomalies are demonstrated in understature children with isolated growth hormone deficiency; enlargement (hyperplasia) of the pituitary may be seen in hypothyroidism (245). In a study of 50 children with precocious puberty, MRI revealed pathological findings often involving the pituitary in 17% of girls an 55.5% of boys (117). However, caution must be taken in interpretation because some children and adolescents exhibit pituitary defects by CT or MRI that are incidental findings and are not associated with hormonal aberrations (66; 138). Pituitary aberrations are also occasionally demonstrated as incidental, unanticipated findings in children without endocrinopathies or major brain malformations and may have an incidence as high as 10% of normal subjects (173). New rapid MRI protocols not only recognize ectopic neurohypophysis but also demonstrate other midline structural abnormalities in the brain (146).

High-resolution MRI and newer MRI techniques, such as MR elastography, perfusion imaging, diffusion-weighted and diffusion-tensor imaging, heavily-weighted T2, and spectroscopy can now provide even more diagnostic information about the abnormal pituitary in children (29; 65). A large, international database demonstrates the correlation of pituitary anomalies with clinical endocrinological deficiencies and association with optic nerve and other structural abnormalities of the brain (53). The diagnosis of pituitary aplasia and dysplasia should not be made without appropriate attempts to image the sella turcica region. MRI of the pituitary and suprasellar region has become much more refined and precise in recent years (94) and even extends to prenatal fetal MRI (36; 190). Though plain skull x-rays may be employed, a more precise examination may be performed with high-resolution CT or, whenever possible, with MRI scans. When the scans reveal a low-density area in the intrasellar region consistent with cerebrospinal fluid, the empty sella diagnosis may be relevant. The diagnosis of an empty sella is made in 20% to 50% of children with pituitary dysfunction (177; 04). A shallow sella turcica may be seen in association with a normal pituitary gland (217). Although the imaging techniques may reveal low-density areas in the sella region, they generally fail to reveal pituitary ectopia. In many cases, however, a small anterior pituitary lobe and lack of visualization of the pituitary stalk may be seen by MRI (225). Pituitary aplasia, dysplasia, and ectopia were found in a considerable number of cases in several postmortem investigations of pituitary morphology in children who died from hypoglycemia secondary to hypopituitarism (217). It was demonstrated that MRI in pituitary dwarfs can reveal unusual intrasellar findings such as pituitary aplasia (257). Familiar hypopituitarism represents a clinically and genetically heterogeneous disorder. In a subset of these families, defects in pit-I, a transcription factor essential for proper pituitary development, have been identified as an underlying molecular cause. These patients present extreme short stature as well as growth hormone, prolactin, and thyroid-stimulating hormone deficiency; however, patients present intact adrenocorticotropic hormone, luteinizing hormone, and follicle-stimulating hormone secretion. MRI evaluation of the pituitary indicated pituitary aplasia in all subjects (167).

Management

The key to successful management is hormone replacement therapy given according to clinical and laboratory findings, including skeletal maturity measures. The replacement therapy rests on the administration of the hormones produced by the target glands except in cases of growth hormone and antidiuretic hormone deficiency when growth hormone and desmopressin acetate, respectively, are administered.

The recommended growth hormone substitution dose is 0.15 to 0.30 mg/kg per week, administered subcutaneously in three divided doses to preferably seven divided doses. The medication may be administered in the clinic or at home by the parents. Compliance with the latter has improved with the new pen injection systems. Maximal response to the treatment is expected in the first years. Therapy should be continued at least until closure of the epiphyses and clinically determined growth arrest.

Thyroid substitution in the form of sodium-L-thyroxin administered orally is the treatment of choice. In neonates, the dose is 10 to 15 µg/kg per day, reduced to 4 µg/kg per day in children, and 2 µg/kg per day in adults. Monodeiodination of thyroxine to liothyronine is the basis for the restoration of normal plasma levels of liothyronine.

Glucocorticosteroids should be substituted in doses not exceeding the equivalent of 15 mg/m2 per day of hydrocortisone, preferably as intermediate-acting drugs such as prednisone. The hormones are administered twice daily. A larger dose is given in the morning, and the remainder is given before dinner in order to mimic the physiological circadian hormone release. It should be stressed that a 2-fold to 4-fold increase of glucocorticosteroid administration may be needed initially in stressful situations that increase the requirements for glucocorticoids. Otherwise, the patient may go into severe adrenal crises. Administration of corticosteroids with mineralocorticoid effects in patients with pituitary aplasia and dysplasia is usually not necessary because adrenal release of aldosterone is maintained independently of adrenocorticotropin stimulation.

In boys with microphallus, a 3-month course of monthly intramuscular injections of 25 mg of testosterone enanthate may enlarge the penis without effects on bone maturation. Sex steroids or gonadotropin may be indicated at the time of normal puberty onset or later as determined by skeletal maturity.

Treatment of posterior pituitary hypofunction is less essential. Oxytocin replacement therapy is generally not appropriate. Antidiuretic hormone deficiency leads to diabetes insipidus, a life-threatening condition in infants who cannot consciously regulate their liquid intake, but it is less of an issue in adults. The treatment of choice is desmopressin acetate, a long-acting synthetic nonapeptide analog of antidiuretic hormone. The dosage for symptomatic relief in adults is 10 to 40 µg daily in two or three divided doses, either as tablets or as a solution inhaled deeply through the nose. In children, 5 to 10 µg daily of desmopressin acetate may be given.

If ectopic neurohypophysis is associated with other brain malformations, the risk of epilepsy is increased and should be treated with antiseizure medications. Sudden death is even reported in rare cases of Joubert syndrome with ectopic neurohypophysis (221).

Endocrine testing should be done periodically in children with growth hormone deficiency because over time they may also develop other pituitary hormonal insufficiencies that were not present earlier (27).

Treatment of these patients requires close monitoring of physical and psychological development as well as repeated lab tests. The question of gene therapy has been put forward. Thus, Davis and McNeilly concluded that “gene therapy for pituitary disease is likely to be feasible in the future but will require careful and extensive evaluation of efficacy and safety, using a variable of possible methods of gene delivery” (52).

Outcomes

Pituitary aplasia and dysplasia is a congenital condition that may be treated with substitution therapy. The condition, however, is permanent, and normal pituitary function cannot be obtained. The mortality varies and is closely related to the lethal underlying condition (ie, anencephaly or severe cases of holoprosencephaly). When the disorder is found in normocephalic children and appropriate substitution therapy instituted, the prognosis quo ad vitam is substantially improved.

The complications to pituitary aplasia and dysplasia may be a result of the condition itself or a result of adverse effects of the treatment. When the condition is treated appropriately the complications are significantly reduced. Lack of gonadotropins may delay pubertal development. In spite of appropriate hormone substitution therapy, short stature and abnormal body proportions are found. Progressive worsening in endocrinopathy throughout childhood may occur so that periodic review of the hormonal status is needed, even in children on replacement therapy (18).

The adverse effects are mostly reversible, and they will not be dealt with here. A few adverse effects do, however, deserve special attention. Patients treated with growth hormone have a risk for leukemia that may be double the risk found in the general population (20). Patients treated before the era of recombinant growth hormone are at risk for developing Creutzfeldt-Jakob disease. Growth hormone and glucocorticoids are diabetogenic.

Media

References

01: Abrahams JJ, Trefelner E, Boulware SD. Idiopathic growth hormone deficiency: MR findings in 35 patients. Am J Neuroradiol 1991;12(1):155-60. PMID 1903575
02: Accornero S, Danesino C, Bastianello S, et al. Duplication of the pituitary stalk in a patient with a heterogenous deletion of chromosome 14 harboring the thyroid transcription factor-1 gene. J Clin Endocrinol Metabol 2010;95:3595-6. PMID 20685887
03: Adly N, Alhashem A, Ammari A, Alkuraya FS. Ciliary genes TBC1D32/C6orf170 and SCLT1 are mutated in patients with OFD type IX. Hum Mutat 2014;35(1):36-40. PMID 24285566
04: Akcurin S, Ocal G, Berberoglu M, Memioglu N. Association of empty sella and neuroendocrine disorders in childhood. Acta Paediatr Jpn 1995;37:347-51. PMID 7645385
05: Alatzoglou KS, Azriyanti A, Rogers N, et al. SOX3 deletion in mouse and human is associated with persistence of the craniopharyngeal canal. J Clin Endocrinol Metab 2014;99(12):e2702-8. PMID 25140394
06: Alatzoglou KS, Gregory LC, Dattani MT. Development of the pituitary gland. Compr Physiol 2020;10(2):389-413. PMID 32163208
07: Al-Bazzaz S, Karamchandani J, Mocarski E, Horvath E, Rotondo F, Kovacs K. Ectopic prolactin-producing pituitary adenoma in a benign ovarian cystic teratoma. Endocr Pathol 2014;25(3):321-3. PMID 24584638
08: AlHatmi A, Raniga S, Al-Shidhani Z, Al-Ajmi E. Partial ectopic posterior pituitary: a rare imaging entity with literature review. Neuroradiol J 2023;3:1971400923121231212369. PMID 37920914
09: Aljeaid D, Lombardo RC, Witte DP, Hopkin RJ. A novel pathogenic variant in OFD1 results in X-linked Joubert syndrome with orofaciodigital features and pituitary aplasia. Am J Med Genet A 2019;179(6):1010-14. PMID 30895720
10: Al-Salihi MM, Qassim T, Aji N, Al-Jebur MS, Rahman MM, Ayyad A. The clinical aspects of septo-optic dysplasia: a narrative review with illustrative case report. Int J Surg Case Rep 2023;109:108575. PMID 37524018
11: Angevine DM. Pathologic anatomy of hypophysis and adrenals in anencephaly. Arch Pathol 1938;26:507-5128.
12: Argyropoulou M, Perignon F, Brauner R, Brunelle F. Magnetic resonance imaging in the diagnosis of growth hormone deficiency. J Pediatr 1992;120(6):886-91. PMID 1593348
13: Aujla PK, Bogdanovic V, Naratadam GT, Raetzman LT. Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure. Dev Dyn 2015;244(8):921-34. PMID 25907274
14: Babala J, Brozman M, Halamova V. Kongenitale lasion der neurohypophyse mit nebenniernehypoplasie. Zentralbl Allg Pathol 1982;126:277-85. PMID 7148183
15: Badawy SZ, Pisarska MD, Wasenko JJ, Buran JJ. Congenital hypopituitarism as a part of suprasellar dysplasia. J Reprod Med 1994;39:643-8. PMID 7996531
16: Balling R, Helwig V, Nadeau J, Neubuser A, Schmahl W, Imai K. Pax genes and skeletal development. Ann N Y Acad Sci 1996;785:27-33. PMID 8702151
17: Bancalari RE, Gregory LC, McCabe MJ, Dattani MT. Pituitary gland development: an update. Endocr Dev 2012;23:1-15. PMID 23182816
18: Bar C, Zadro C, Diene G, et al. Pituitary stalk interruption syndrome from infancy to adulthood: clinical, hormonal, and radiological assessment according to the initial presentation. PLoS One 2015;10(11):e0142354. PMID 26562670
19: Bashamboo A, Bignon-Topalovic J, Moussi N, McElreavey K, Brauner R. Mutations in the human ROBO1 gene in pituitary stalk interruption syndrome. J Clin Endocrinol Metab 2017;102(7):2401-6. PMID 28402530
20: Behrman RE. Nelson textbook of pediatrics. 14th ed. Philadelphia: WB Saunders, 1992.
21: Bellfield EJ, Chan J, Durrin S, Lindgren V, Shad Z, Boucher-Berry C. Anterior pituitary aplasia in an infant with ring chromosome 18p deletion. Case Rep Endocrinol 2016;2853178. PMID 27843654
22: Benvenga S, Klose M, Vita R, Feldt-Rasmussen U. Less known aspects of central hypothyroidism: Part 2 – congenital etiologies. J Clin Transl Endocrinol 2018;14:5-11. PMID 30294553
23: Berger S, Bosmia AN. Diagnosis of septo-optic dysplasia in a neonate with hypernatremia, hypoglycemia, and persistent hypothermia. J Pediatr Endocrinol Metab 2013;26(11-12):1167-9. PMID 23813351
24: Bergeron C, Kovacs K, Bilbao JM. Primary empty sella. Arch Intern Med 1979;139:248-9. PMID 434984
25: Blethen SL, Weldon VV. Hypopituitarism and septo-optic "dysplasia" in first cousins. Am J Med Genet 1985;21:123-9. PMID 4003437
26: Blizzard RM, Alberts M. Hypopituitarism, hypoadrenalism, and hypogonadism in the newborn infant. J Pediatr 1956;48:782-92. PMID 13332518
27: Blum WF, Deal C, Zimmermann AG, et al. Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with idiopathic isolated GH deficiency. Eur J Endocrinol 2013;170(1):13-21. PMID 24088548
28: Boruah DK, Sanyal S, Prakash A, et al. Extra-pituitary cerebral anomalies in pediatric patients of ectopic neurohypophysis: an uncommon association. J Clin Imaging Sci 2017;7:19. PMID 28584686
29: Bou-Ayache JM, Delman BN. Advances in imaging of the pediatric pituitary gland. Endocrinol Metab Clin North Am 2016;45(2):443-52. PMID 27241974
30: Braquehais MD, Picouto MD, Casas M, Sher L. Hypothalamic-pituitary-adrenal axis dysfunction as a neurobiological correlate of emotional dysregulation in adolescent suicide. World J Pediatr 2012;8:197-206. PMID 22886191
31: Brant-Zawadzki M, Bradley W, Cambray-Forker J. MRI of the brain II. Philadelphia: Lippincott Williams and Wilkins, 2001.
32: Brauner R, Bignon-Topalovic J, Bashamboo A, McElreavey K. Pituitary stalk interruption syndrome is characterized by genetic heterogeneity. PLoS One 2020;15(12):e0242358
33: Brewer DB. Congenital absence of the pituitary gland and its consequences. J Path Bact 1957;LXXIII:59-61.
34: Brodsky MC, Glasier CM. Optic nerve hypoplasia: clinical significance of associated central nervous system abnormalities on magnetic resonance imaging. Arch Ophthalmol 1993;111(1):66-74. PMID 8424727
35: Capra V, Severino M, Rossi A, et al. Pituitary deficiency and congenital infiltrating lipomatosis of the face in a girl with deletion of chromosome 1q24.3q31.1. Am J Med Genet A 2014;164A(2):495-9. PMID 24311370
36: Cervantes LF, Altman NR, Santiago Medina L. Pituitary aplasia. Radiology 2006;241:936-8. PMID 17114634
37: Chabrolle JP, Labenne M, Cailliez D, Poinsot J, Bruel H, Vercoustre L. Hypoglossia, situs inversus and absence of the pituitary in a neonate: teratogenic effect of maternal hyperthermia. Arch de Pediatr 1998;5(2):163-6. PMID 10223138
38: Chapman PR, Singhal A, Gaddemanugu S, Prattipati V. Neuroimaging of the pituitary gland: practical anatomy and physiology. Radiol Clin N Amer 2020;58(6):1115-33. PMID 33040852
39: Chariker M, Ford R, Morrison C, et al. Pituitary duplication with nasopharyngeal teratoma and cleft palate. J Craniofac Surg 2011;22:755-8. PMID 21415659
40: Chen S, Léger J, Garel C, Hassan M, Czernichow P. Growth hormone deficiency with ectopic neurohypophysis: anatomical variations and relationship between the visibility of the pituitary stalk asserted by magnetic resonance imaging and anterior pituitary function. J Clin Endocrinol Metab 1999;84(7):2408-13. PMID 10404812
41: Chiaramonte I, Cappello G, Uccello A, et al. Vascular cerebral anomalies associated with septo-optic dysplasia. A case report. Neuroradiol J 2013;26(1):66-70. PMID 23859170
42: Chin KY. The endocrine glands of anencephalic fetuses. Chin Med J 1938;(Suppl 2):63-90.
43: Cohen MM, Gorlin RJ. Genetic considerations in a sibship of cyclopia and clefts. Birth defects: original article series 1969;V:113-8.
44: Costigan DC, Daneman D, Harwood-Nash D, Holland FJ. The "empty sella" in childhood. Clin Pediatr 1984;23:437-40. PMID 6734018
45: Costin G, Murphree AL. Hypothalamic-pituitary function in children with optic nerve hypoplasia. Am J Dis Child 1985;139:249-54. PMID 2983530
46: Dahl S, Kristoffersen Wilberg M, Teär Fahnehjelm K, Sävendahl, Wickström R. High prevalence of pituitary hormone deficiency in both unilateral and bilateral optic nerve hypoplasia. Acta Paediatr 2019;108(9):1677-85. PMID 30740788
47: Dalvi M, Walker BR, Strachan NW, Zammitt NN, Gibb FW. The prevalence of structural pituitary abnormalities by MRI scanning in men presenting with isolated hypogonadotrophic hypogonadism. Clin Endocrinol (Oxf) 2016;84(6):858-61. PMID 26733239
48: Dattani MT, Martinez-Barbera JP, Thomas PQ, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998;19(2):125-33. PMID 9620767
49: Dattani MT, Martinez-Barbera JP, Thomas PQ, et al. HESX1: a novel gene implicated in a familiar form of septo-optic dysplasia. Acta Paediatr 1999;88(433):49-54. PMID 10626545
50: Dattani MT, Robinson IC. The molecular basis for developmental disorders of the pituitary gland in man. Clin Genet 2000;57(5):337-46. PMID 10852367
51: David O, Eskin-Schwartz M, Ling G, et al. Pituitary stalk interruption syndrome broadens the clinical spectrum of the TTC26 ciliopathy. Clin Genet 2020;98(3):303-7. PMID 32617964
52: Davis JR, McNeilly A. Is pituitary gene therapy realistic. Clin Endocrin 2001;55:427-33. PMID 11678822
53: Deal C, Hasselmann C, Pfaffle RW, et al. Associations between pituitary imaging abnormalities and clinical and biochemical phenotypes in children with congenital growth hormone deficiency: data from an international observational study. Horm Res Paediatr 2013;79(5):283-92. PMID 23689058
54: Dean L. McCune-Albright syndrome. In: Pratt V, McLeod H, Dean L, Malheiro A, Rubinstein W, editors. Medical genetics summaries [Internet]. Bethesda, MD: National Center for Biotechnology Information, 2017.
55: De Sanctis V, Soliman AT, Elsedfy H, Soliman NA, Elalaily R, El Kholy M. Precocious puberty following traumatic brain injury in early childhood: a review of the literature. Pediatr Endocrinol Rev 2015;13(1):458-64. PMID 26540762
56: Devesa J, Alonso A, López N, et al. Growth hormone (GH) and rehabilitation promoted distal innervation in a child affected by caudal regression syndrome. Int J Mol Sci 2017;18(1):230. PMID 28124993
57: Doyle W. Folic acid in prevention of neural tube defects [letter]. Lancet 1995;345:389-90. PMID 7845140
58: Durmaz B, Cogulu O, Dizdarer C, Stobbe H, Pfaeffle R, Ozkinay F. A novel homozygous HESX1 mutation causes panhypopituitarism without midline defects and optic nerve anomalies. J Pediatr Endocrinol Metal 2011;24(9-10):779-82. PMID 22145475
59: Dutour A. A new step understood in the cascade of tissue-specific regulators orchestrating pituitary lineage determination: the prophet of Pit-1 (Prop-1). Eur J Endocrinol 1997;137(6):616-7. PMID 9437225
60: Dutta D, Jain R, Kumar M, Thukral A, Chowdhury S, Mukhopadhyay S. Solitary median maxillary central incisor, a clinical predictor of hypoplastic anterior pituitary, ectopic neurohypophysis and growth hormone deficiency. J Pediatr Endocrinol Metab 2013;26(9-10):809-10. PMID 23729612
61: Dutta D, Selvan C, Mukhopadhyay S. Multiple pituitary hormone deficiency, empty sella and ectopic neurohypophysis in Turner syndrome. Indian Pediatr 2015;52(9):803-4. PMID 26519720
62: Edmonds HW. Pituitary, adrenal and thyroid in cyclopia. Arch Pathol 1950;50:727-35. PMID 14789318
63: el Amraoui A, Dubois PM. Experimental evidence for an early commitment of gonadotropin-releasing hormone neurons, with special regard to their origin from the ectoderm of nasal cavity presumptive territory. Neuroendocrinology 1993;57(6):991-1002. PMID 8232774
64: Ellyin F, Khatir AH, Singh AP. Hypothalamic-pituitary functions in patients with transsphenoidal encephalocele and midfacial anomalies. J Clin Endocrinol Metab 1980;51:854-6. PMID 6998999
65: El Sanharawi I, Tzarouchi L, Cardoen L, et al. High-resolution heavily T2-weighted magnetic resonance imaging for evaluation of the pituitary stalk in children with ectopic neurohypophysis. Pediatr Radiol 2017;47(5):599-605. PMID 28255689
66: Esteves C, Neves C, Augusto L, et al. Pituitary incidentalomas: analysis of a neuroradiological cohort. Pituitary 2015;18(6):777-81. PMID 25800168
67: Fang Q, Benedetti AF, Ma Q, et al. HESX1 mutations in patients with congenital hypopituitarism: variable phenotypes with the same genotype. Clin Endocrinol (Oxf) 2016;85(3):408-14. PMID 27000987
68: Feingold M, Shiere F, Fogels HR, Donaldson DD. Rieger's syndrome. Pediatrics 1969;44:564-9. PMID 5346635
69: Fernandez-Marmiesse A, Pérez-Poyato MS, Fontalba A, et al. Septo-optic dysplasia caused by a novel FLNA splice site mutation: a case report. BMC Med Genet 2019;20(1):112. PMID 5346635
70: Fraiser SD. Abnormalities of growth. In: Collu R, Ducharme JR, Guyda HJ, editors. Pediatric endocrinology. 2nd edition. New York: Raven, 1989:171-216.
71: França MM, Jorge AA, Carvalho LR, et al. Novel heterozygous nonsense GLI2 mutations in patients with hypopituitarism and ectopic posterior pituitary lobe without holoprosencephaly. J Clin Endocrin Metab 2010;95(11):E384-91. PMID 20685856
72: Frisch H, Kim C, Hausler G, Pfaffle R. Combined pituitary hormone deficiency and pituitary hypoplasia due to a mutation of the Pit-1 gene. Clin Endocrinol (Oxf) 2000;52(5):661-5. PMID 10792348
73: Fujisawa I, Kikuchi K, Nishimura K, et al. Transection of the pituitary stalk: development of an ectopic posterior lobe assessed with MRI imaging. Radiology 1987;165(2):487-9. PMID 3659371
74: Gaddikeri S, Vattoth S, Riley KO, et al. Rathke cleft cyst. MRI criteria for presumptive diagnosis. Neurosciences (Riyadh) 2013;18(3):258-63. PMID 23887217
75: Gan RW, Jose J, Bahl A. Large pituitary colloid cyst causing visual and hormonal defects. BMI Case Rep 2021;14(7):e243221. PMID 34244188
76: García-Filion P, Almarzouki H, Fink C, Geffner M, Nelson M, Borchert M. Brain malformations do not predict hypopituitarism in young children with optic nerve hypoplasia. Horm Res Paediatr 2017;88(3-4):251-7. PMID 28848142
77: Garne E, Rissmann A, Addor MC, et al. Epidemiology of septo-optic dysplasia with focus on prevalence and maternal age – a EUROCAP study. Eur J Med Genet 2018;61(9):483-8. PMID 29753093
78: Gaston-Massuet C, McCabe MJ, Scagliotti V, et al. Transcription factor 7-like 1 is involved in hypothalamo-pituitary axis development in mice and humans. Proc Natl Acad Sci USA 2016;113(5):E548-57. PMID 26764381
79: Gat-Yablonski G. Brain development is a multi-level regulated process – the case of the OTX2 gene. Pediatr Endocrinol Rev 2011;9:422-30. PMID 22783640
80: Ghervan C, Young J. Congenital hypogonadotropic hypogonadism and Kallmann syndrome in males [Article in French]. Presse Med 2014;43(2):152-61. PMID 24456696
81: Ginat DT, Holbrook EH, Faquin W, Curtin HD. Nasal hamartoma associated with duplicated pituitary. J Comput Assist Tomogr 2013;37(3):369-70. PMID 23674006
82: Giordano M. Genetic causes of isolated and combined pituitary hormone deficiency. Best Pract Res Clin Endocrinol Metabol 2016;30(6):679-91. PMID 27974184
83: Glasker S, Vortmeyer AO, Lafferty AR, et al. Hereditary pituitary hyperplasia with infantile gigantism. J Clin Endocrinol Metab 2011;96:E2078-87. PMID 21976722
84: Gleiberman AS, Fedtsova NG, Rosenfeld MG. Tissue interactions in the induction of anterior pituitary: role of the ventral diencephalon, mesenchyme, and notochord. Dev Biol 1999;213(2):340-53. PMID 10479452
85: Greaves RF, Pitkin J, Ho CS, Baglin J, Hunt RW, Zacharin MR. Hormone modeling in preterm neonates: establishment of pituitary and steroid hormone reference intervals. J Clin Endocrinol Metab 2015;100:1097-103. PMID 25562509
86: Gregory LC, Gevers EF, Baker J, et al. Structural pituitary abnormalities associated with CHARGE syndrome. J Clin Endocrinol Metab 2013;98(4):E737-43. PMID 23526466
87: Gregory LC, Humayun KN, Turton JP, McCabe MJ, Rhodes SJ, Dattani MT. Novel lethal form of congenital hypopituitarism associated with the first recessive LHX4 mutation. J Clin Endocrinol Metab 2015;100(6):2158-64. PMID 25871839
88: Guitelman M, García-Basavilbaso N, Vitale M, et al. Primary empty sella (PES): a review of 175 cases. Pituitary 2013;16:270-4. PMID 22875743
89: Haagen M, Akkurt I, Blunck W. Hypoglycemia and cholestatic jaundice in congenital panhypopituitarism. Monatsschr Kinderheilkund 1989;137:678-80. PMID 2586535
90: Hall JG, Pallister PD, Clarren SK, et al. Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus, and postnatal polydactyly--a new syndrome. Part 1: clinical, causal, and pathogenetic considerations. Am J Med Genet 1980;7(1):47-74. PMID 7211952
91: Hamed SA. The effect of antiepileptic drugs on thyroid hormonal function: causes and implications. Expert Rev Clin Pharmacol 2015;8(6):741-50. PMID 26437373
92: Hamilton J, Blaser S, Daneman D. MR imaging in idiopathic growth hormone deficiency. Am J Neuroradiol 1998;19(9):1609-15. PMID 9802480
93: Herman SP, Baggenstoss AH, Cloutier MD. Liver dysfunction and histologic abnormalities in neonatal hypopituitarism. J Pediatr 1975;87:892-5. PMID 1185390
94: Hess CP, Dillon WP. Imaging the pituitary and parasellar region. Neurosurg Clin N Amer 2012;23:529-42. PMID 23040741
95: Horton JC, Barkovich AJ. Bilateral optic disc pits with posterior pituitary ectopia. J Neuroophthalmol 2017;37(4):401-2. PMID 28542028
96: Hu F, Sun L. Recognizable type of pituitary, heart, kidney and skeletal dysplasia mostly caused by SEMA3A mutation: a case report. World J Clin Cases 2019;7(20):3310-5. PMID 31667184
97: Ikeda H, Suzuki J, Sasano N, Niizuma H. The development and morphogenesis of the human pituitary gland. Anat Embryol (Berl) 1988;178(4):327-36. PMID 3177887
98: Inamo Y, Harada K. Agenesis of the internal carotid artery and congenital pituitary hypoplasia: proposal of a cause of congenital hypopituitarism. Eur J Pediatr 2003;162(9):610-2. PMID 12856176
99: Iorgi ND, Allegri AE, Napoli F, et al. The use of neuroimaging for disorders of pituitary development. Clin Endocrinol (Oxford) 2012;76(2):161-76. PMID 21955099
100: Izenberg N, Rosenblum M, Parks JS. The endocrine spectrum of septo-optic dysplasia. Clin Pediatr 1984;23:632-6. PMID 6488662
101: Jamsheer A, Olech EM, Kozlowski K, et al. Exome sequencing reveals two novel compound heterozygous XYLT1 mutations in a Polish patient with Desbuquois dysplasia type 2 and growth hormone deficiency. J Hum Genet 2016;61(7):577-83. PMID 27030147
102: Jedraszak G, Braun K, Receveur A, et al. Growth hormone deficiency and pituitary malformation in a recurrent cat-eye syndrome: a family report. Ann Endocrinol (Paris) 2015;76(5):629-34. PMID 26518262
103: Jethwani DP, Mahadevan A, Ramamurthy BS, et al. Septo-optic dysplasia: an autopsy study of a 23-week fetus. Clin Neuropathol 2012;31:44-50. PMID 22192704
104: Johnson JD, Hansen RC, Albritton WL, Werthemann U, Christiansen RO. Hypoplasia of the anterior pituitary and neonatal hypoglycemia. J Pediatr 1973;82:634-41. PMID 4698339
105: Jones GE, Robertson L, Warman P, Craft EV, Cresswell L, Vasudevan PC. 14q22.3 microdeletion encompassing OTX2 in a five-generation family with microphthalmia, pituitary abnormalities, and intellectual disability. Ophthalmic Genet 2016;37(3):352-3. PMID 26860946
106: Kahn BM, Sorman TS, Lovelace K, Hong M, Krauss RS, Epstein DJ. Prenatal ethanol exposure in mice phenocopies Cdon mutation by impeding Shh function in the etiology of optic nerve hypoplasia. Dis Model Mech 2017;10(1):29-37. PMID 27935818
107: Kanakatti Shankar R, Giri N, Lodish MB, et al. Pituitary abnormalities in patients with Fanconi anaemia. Clin Endocrinol (Oxford) 2016;84(2):307-9. PMID 26300308
108: Kano M, Sasaki H, Miwata T, Suga H. Recipe for pituitary organoids. Front Endocrinol (Lausanne) 2023;13:1025825. PMID 36743928
109: Karaca E, Buyukkaya R, Pehlivan D, et al. Whole-exome sequencing identifies homozygous GPR161 mutation in a family with pituitary stalk interruption syndrome. J Clin Endocrinol Metab 2015;100(1):e140-7. PMID 25322266
110: Katavenin P, Cheunsuchon P, Grant E, et al. Rathke’s cleft cysts in children and adolescents: association with female puberty. J Pediatr Endocrinol Metab 2010;23:1175-80. PMID 21284332
111: Kato Y, Yoshida S, Kato T. Missing pieces of the pituitary gland puzzle: participation of extra-adrenohypophyseal placode-lineage cells in the adult pituitary gland. Cell Tiss Res 2023;394(3):487-96. PMID 37650920
112: Katz J, Benamot J, Kadis L, editors. Anesthesia and uncommon diseases. 3rd edition. Philadelphia: WB Saunders, 1990.
113: Kaufman BA, Kaufman B, Mapstone TB. Pituitary stalk agenesis: magnetic resonance imaging of ‘ectopic posterior lobe’ with surgical correlations. Pediatr Neurosci 1988;14(3):140-4. PMID 3252215
114: Kauschansky A, Genel M, Smith GJ. Congenital hypopituitarism in female infants. Its association with hypoglycemia and hypothyroidism. Am J Dis Child 1979;133:165-9. PMID 420186
115: Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT. Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 2009;30(7):790-829. PMID 19837867
116: Kelly WM, Kucharczyk W, Kucharczk J, et al. Posterior pituitary ectopia; an MR feature of pituitary dwarfism. Am J Neuroradiol 1988;9(3):453-60. PMID 3132820
117: Kendirci NP, Kaba I, Fidan N. Evaluation of pituitary/cranial imaging results of central puberty precocious cases. Niger J Clin Pract 2022;25(4):466-72.
118: Kewitz G, Girard J, Probst A, et al. Septo-optic pituitary dysplasia. Helv Paediatr Acta 1984;39(4):355-64. PMID 6543848
119: Khaper T, Bunge M, Clark I, et al. Increasing incidence of optic nerve hypoplasia/septo-optic dysplasia spectrum: geographic clustering in northern Canada. Paediatr Child Health 2017;22(8):445-53. PMID 29479262
120: Kim S, Dillon WP, Hope TA, et al. Ectopic thyroid-stimulating hormone-secreting pituitary adenoma of the nasopharynx diagnosed by gallium 68 DOTATATE positron emission tomography/computed tomography. World Neurosurg 2019;125:400-4. PMID 30797906
121: Kjaer I, Fischer-Hansen B. Human fetal pituitary gland in holoprosencephaly and anencephaly. J Craniofac Genet Dev Biol 1995c;15:222-9. PMID 8719351
122: Kjaer I, Fischer-Hansen B. Postmortem axial skeletal radiography can reveal fetal CNS malformations. APMIS 1995a;103:574-81. PMID 7576575
123: Kjaer I, Fischer-Hansen B. The adenohypophysis and the cranial base in early human development. J Craniofac Genet Dev Biol 1995b;15:157-61. PMID 8642055
124: Kjaer I, Fischer-Hansen B. The prenatal pituitary gland--hidden and forgotten. Pediatr Neurol 2000;22:155-6. PMID 10738925
125: Kjaer I, Fischer-Hansen B, Keeling JW. The axial skeleton and the pituitary gland in human fetuses with spina bifida and cranial encephalocele. Pediatr Pathol 1996;16:909-26. PMID 9025889
126: Kjaer I, Fischer-Hansen B, Reintoft I, Keeling JW. Pituitary gland and axial skeletal malformations in human fetuses with spina bifida. Eur J Pediatr Surg 1999b;9:354-8. PMID 10661842
127: Kjaer I, Keeling JW, Fischer Hansen B. The Prenatal Human Cranium. Munksgaard, Copenhagen, 1999a.
128: Kjaer I, Keeling JW, Graem N. The midline craniofacial skeleton in holoprosencephalic fetuses. J Med Genet 1991;28:846-55. PMID 1757961
129: Kjaer I, Keeling JW, Reintoft I, Hjalgrim H, Nolting D, Fischer Hansen B. Pituitary gland and sella turcica in trisomy 18 fetuses. Am J Med Genet 1998a;76(1)92. PMID 9508072
130: Kjaer I, Keeling JW, Reintoft I, Nolting D, Fischer-Hansen B. Pituitary gland and sella turcica in human trisomy 21 fetuses related to axial skeletal development. Am J Med Genet 1998b;80:494-500. PMID 9880215
131: Kjaer I, Reintoft I, Poulsen H, et al. A new craniofacial disorder involving hypertelorism and malformations of external nose, palate and pituitary gland. J Craniofac Genet Dev Biol 1997;17(1):23-34. PMID 9211119
132: Kjaer I, Russell BG. The craniopharyngeal canal indicating the presence of pharyngeal adenopituitary tissue. Eur J Radiol 1995;20:212-4. PMID 8536753
133: Koizumi M, Ida S, Shoji Y, Etani Y, Hatsukawa Y, Okamoto N. Endocrine status of patients with septo-optic dysplasia: fourteen Japanese cases. Clin Pediatr Endocrinol 2017;26(2):89-98. PMID 28458461
134: Kornreich L, Horev G, Lazar L, Schwarz M, Sulkes J, Pertzelan A. MR findings in growth hormone deficiency: correlation with severity of hypopituitarism. AJNR Am J Neuroradiol 1998;19(8):1495-9. PMID 9763384
135: Kosaki K, Matsuo N, Tamai S, Miyama S, Momoshima S. Isolated aplasia of the anterior pituitary as a cause of congenital panhypopituitarism. Horm Res 1991;35:226-8. PMID 1819546
136: Kuriyama M, Shigematsu Y, Konishi K, et al. Septo-optic dysplasia with infantile spasm. Pediatr Neurol 1988;4(1)-5. PMID 3233109
137: Lamine F, Kanoun F, Chihaoui M, et al. Unilateral agenesis of internal carotid artery associated with congenital combined pituitary hormone deficiency and pituitary stalk interruption without HESX1, LHX4 or OTX2 mutation: a case report. Pituitary 2012;suppl 1:S81-6. PMID 22797803
138: Langlois F, Fleseriu M. What to do with incidentally discovered pituitary abnormalities? Med Clin North Am 2021;105(6):1081-98. PMID 34688416
139: Lee P, Krisht KM, Mukunyadzi P, Krisht AF. Resection of an isolated pituitary stalk epidermoid cyst through a pretemporal approach: case report and review of the literature. World Neurosurg 2021;146:26-30. PMID 32920157
140: Lennox B, Russell DS. Dystopia of the neurohypophysis: two cases. J Pathol Bact 1951;LXIII:485-90. PMID 14874163
141: Leon-González M, García-Peñas JJ, Puertas-Bordallo D, et al. [Natural course of septo-optic dysplasia: retrospective análisis of 20 cases]. (Spanish) Rev Neurol (Barcelona) 2012;54:321-31. PMID 22403144
142: Li S, Crenshaw EB 3rd, Rawson EJ, DM, Swanson LW, Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutation in the POU-domain gene pit-1. Nature 1990;347(6293):528-33. PMID 1977085
143: Lonero A, Delvecchio M, Primignani P, et al. A novel OTX2 gene frameshift mutation in a child with microphthalmia, ectopic pituitary and growth hormone deficiency. J Pediatr Endocrinol Metab 2016;29(5):603-5. PMID 26974134
144: Lovrencic MK, Oberiter V, Banovac ZR, Schmutzer L, Petek M. Pituitary function in a patient with septo-optic dysplasia and pituitary dwarfism (Kaplan-Grumbach-Hoyt syndrome). Eur J Pediatr 1978;129:47-53. PMID 679955
145: Lucci-Cordisco E, Scommegna S, Orteschi D, et al. Three unrelated patients with congenital anterior pituitary aplasia and a characteristic physical and neuropsychological phenotype: a new syndrome. Am J Med Genet 2012;158A:2750-5. PMID 22987613
146: Lyra A, de Faria Guimarães D, Meira AS, et al. Extra-pituitary midline structural abnormalities associated with ectopic posterior pituitary detected on a new rapid MRI protocol (FAST1.2). Arch Endocrinol Metab 2022;66(6):831-6. PMID 35929902
147: Macchiaroli A, Kelberman D, Auriemma RS, et al. A novel heterozygous SOX2 mutation causing congenital bilateral anophthalmia, hypogonadotropic hypogonadism and growth hormone deficiency. Gene 2014;534(2):282-5. PMID 24211324
148: Machinis K, Pantel J, Netchine I, et al. Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 2001;69(5):961-8. PMID 11567216
149: Maghnie M, Triulzi F, Larizza D, et al. Hypothalamic-pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities. J Clin Endocrinol Metab 1991;73(1):79-83. PMID 1904454
150: Mahomed N, Motshudi T. The ectopic posterior pituitary gland. S Afr J Surg 2013;51(4):148. PMID 24209704
151: Margalith D, Tze WJ, Jan JE. Congenital optic nerve hypoplasia with hypothalamic-pituitary dysplasia. Am J Dis Child 1985;139:361-6. PMID 3976626
152: Marzuillo P, Grandone A, Coppola R, et al. Novel cAMP binding protein-BP (CREBBP) mutation in a girl with Rubinstein-Taybi syndrome, GH deficiency, Arnold-Chiari malformation and pituitary hypoplasia. BMC Med Genet 2013;14:28. PMID 23432975
153: Massimino CR, Smilari P, Greco F, et al. Poland syndrome with atypical malformations associated to a de novo 1.5 Mb Xp22.31 duplication. Neuropediatrics 2020;51(5):359-63. PMID 32016944
154: McCabe MJ, Alatzoglou KS, Dattani MT. Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond. Best Pract Res Clin Endocrinol Metab 2011a;25:115-24. PMID 21396578
155: McCabe MJ, Gaston-Massuet C, Tziaferi V, et al. Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypthalamo-pituitary dysfunction. J Clin Endocrinol Metab 2011b;96(10):E1709-18. PMID 21832120
156: McCormack SE, Li D, Kim YJ, et al. Digenic inheritance of PROKR2 and WDR11 mutations in pituitary stalk interruption syndrome. J Clin Endocrinol Metab 2017;102(7):2501-7. PMID 28453858
157: McPhie JL, Beck JS. The histological features and human growth hormone content of the pharyngeal pituitary gland in normal and endocrinologically-disturbed patients. Clin Endocrinol 1973;2:157-73. PMID 4588948
158: Melchionna RH, Moore RA. The pharyngeal pituitary gland. Am J Pathol 1938;14:763-71. PMID 19970416
159: Milic I, Samardžić M, Djorić I, Tasić G, Djulejić V, Marinković S. Craniovertebral anomalies associated with pituitary gland duplication. Folia Morphol (Warsz) 2015;74(4):524-31. PMID 26620517
160: Miller RD, editor. Anesthesia. 3rd ed. New York: Churchill Livingstone, 1990.
161: Min W, Liu C, Yang Y, et al. Alterations in the hypothalamic-pituitary-adrenal/thyroid (HPA/HPT) axes correlated with the clinical manifestations of depression. Prog Neuropsychopharmacol Biol Psychiatry 2012;39:206-11. PMID 22750689
162: Mitchell LA, Thomas PQ, Zacharin MR, Scheffer IE. Ectopic posterior pituitary lobe and periventricular heterotopia: cerebral malformations with the same underlying mechanisms. Am J Neuroradiol 2002;23(9):1475-81. PMID 12372734
163: Morishima A, Aranoff GS. Syndrome of septo-optic-pituitary dysplasia: the clinical spectrum. Brain Dev 1986;8:233-9. PMID 3766900
164: Mosier HD. Hypoplasia of the pituitary and adrenal cortex. J Pediatr 1956;48:633-9. PMID 13307364
165: Nagasaki K, Kubota T, Kobayashi H, et al. Clinical characteristics of septo-optic dysplasia accompanied by congenital central hypothyroidism in Japan. Clin Pediatr Endocrinol 2017;26(4):207-13. PMID 29026269
166: Nalawade R, Bhate M. Septo-optic dysplasia: a case series of 33 patients. Neuroophthalmology 2024;48(1):13-8. PMID 38357618
167: Nogueira CR, Leite CC, Chedid EP, et al. Autosomal recessive deficiency of combined pituitary hormones (except ACTH) in a consanguineous Brazilian kindred. J Endocrin Invest 1998;21(6):386-91. PMID 9699131
168: Nordgarden H, Reintoft I, Nolting D, Fischer-Hansen B, Kjaer I. Craniofacial tissues including tooth buds in fetal hypohidrotic ectodermal dysplasia. Oral Dis 2001;7:163-70. PMID 11495192
169: Ohta K, Nobukuni Y, Mitsubuchi H, et al. Mutations in the Pit-1 gene in children with combined pituitary hormone deficiency. Biochem Biophys Res Commun 1992;189(2):851-5. PMID 1472057
170: Olszewska M, Kielbasa G, Wójcik M, Zygmunt-Górska A, Starzyk JB. A case report of severe panhypopituitarism in a newborn delivered by a woman with Turner syndrome. Neuro Endocrinol Lett 2015;36(8):734-6. PMID 26921572
171: Ören NC, Cagiltay E, Akay F, Toyran S. Panhypopituitarism with ectopic posterior pituitary lobe, heterotopia, polymicrogyria, corpus callosum dysgenesis, and optic chiasm/nerve hypoplasia: is that an undefined neuronal migration syndrome? Am J Neuroradiol 2015;36(5):e33-5. PMID 25721080
172: Ozen S, Sismek DG, Onder A, Darcan S. Renal anomalies associated with ectopic neurohypophysis. J Clin Res Pediatr Endocrinol 2011;3(2):56-9. PMID 21750632
173: Paschou SA, Vryonidou A, Goulis DG. Pituitary incidentalomas: a guide to assessment, treatment and follow-up. Maturitas 2016;92:143-9. PMID 27621252
174: Perez C, Dastot-Le Moal F, Collot N, et al. Screening of LHX2 in patients presenting growth retardation with posterior pituitary and ocular abnormalities. Eur J Endocrinol 2012;167:85-91. PMID 22535646
175: Petridis AK, Barth H. Pituitary stalk duplication in ventral-dorsal direction in a patient with pituitary gland adenoma and aqueductal stenosis. Clin Anat 2010;23:879-80. PMID 20830795
176: Pinto G, Netchine I, Sobrier ML, Brunelle F, Souberbielle JC, Brauner R. Pituitary stalk interruption syndrome: a clinical-biological-genetic assessment of its pathogenesis. J Clin Endocrinol Metab 1997;82(10):3450-4. PMID 9329385
177: Pocecco M, de Campo C, Marinoni S, et al. High frequency of empty sella syndrome in children with growth hormone deficiency. Helv Paediatr Acta 1988;43(4):295-301. PMID 2785096
178: Pommereit D, Pieler T, Hollemann T. Xpit3: a member of the Rieg/Pitx gene family expressed during pituitary and lens formation in Xenopus laevis. Mech of Dev, 2001;102:255-7. PMID 11287205
179: Prezioso G, Petraroli M, Bergonzani M, et al. Duplication of the pituitary gland (DPG)-plus syndrome associated with midline anomalies and precocious puberty: a case report and review of the literature. Front Endocrinol (Lausanne) 2021;12:685888. PMID 34122353
180: Priesel A. Über die dystopie der neurohypophyse. Virch Arch Pathol Anat Physiol Klin Med 1927;266:407-15.
181: Qian X, Fouzdar Jain S, Morgan LA, Kruse T, Cabrera M, Suh DW. Neuroimaging and endocrine disorders in paediatric optic nerve hypoplasia. Br J Ophthalmol 2018;102(7):906-10. PMID 28982953
182: Quentien MH, Pitoia F, Gunz G, Guillet MP, Enjalbert A, Pellegrini I. Regulation of prolactin, GH, and Pit-1 gene expression in anterior pituitary by Pitx2: an approach using Pitx2 mutants. Endocrin 2002;143(8):2839-51. PMID 12130547
183: Radovick S, Cohen LE, Wondisford FE. The molecular basis of hypopituitarism. Horm Res 1998;49:30-6. PMID 9554467
184: Rahhal MN, Kassern LS. An unexpected combination of prolactinoma and septo-optic dysplasia. AACE Clin Case Rep 2019;5(5):e282-6. PMID 31967053
185: Ram N, Ali SA, Hussain SZ. Pituitary stalk interruption syndrome presenting as short stature: a case report. J Med Case Rep 2014;8:445. PMID 25524465
186: Rappaport EB, Ulstrom RA, Gorlin RJ, Lucky AW, Colle E, Miser J. Solitary maxillary central incisor and short stature. J Pediatr 1977;91(6):924-8. PMID 925821
187: Reid JR. Congenital absence of the pituitary gland. J Pediatr 1960;55:658-64. PMID 14437088
188: Reis P, Mourão J. Septo-optic dysplasia/de Morsier’s syndrome. Saudi J Anaesth 2017;11(1):106-7. PMID 28217067
189: Reynaud R, Albarel F, Saveanu A, et al. Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms. Eur J Endocrinol 2011;164:457-65. PMID 21270112
190: Righini A, Parazzini C, Doneda C, Arrigoni F, Triuizi F. Prenatal MR imaging of the normal pituitary stalk. Am J Neuroradiol 2009;30:1014-6. PMID 19193754
191: Roessler E, Belloni E, Gaudenz K, et al. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 1996;14(3):357-60. PMID 8896572
192: Roessmann U, Velasco ME, Small EJ, Hori A. Neuropathology of "septo-optic dysplasia" (de Morsier syndrome) with immunohistochemical studies of the hypothalamus and pituitary gland. J Neuropathol Exp Neurol 1987;46:597-608. PMID 3625236
193: Rudman D, Davis T, Priest JH, et al. Prevalence of growth hormone deficiency in children with cleft lip or palate. J Pediatr 1978;93(3):378-82. PMID 211214
194: Sadeghi-Nejad A, Senior B. A familial syndrome of isolated "aplasia" of the anterior pituitary. J Pediatr 1974a;84:79-84. PMID 12119961
195: Sadeghi-Nejad A, Senior B. Autosomal dominant transmission of isolated growth hormone deficiency in iris-dental dysplasia (Rieger's syndrome). J Pediatr 1974b;85:644-8. PMID 4214375
196: Saeger W. Ectopia of the pituitary. Pathologe 2018;39(5):373-8. PMID 30120512
197: Salman MS, Hossain S, Rozovsky K. Neuroimaging feature in children with optic nerve hypoplasia and septo-optic-pituitary dysplasia. Can J Neurol Sci 2023;26:1-9. PMID 37492885
198: Salman MS, Hossain S, Carson E, Clark IH, Rozovsky K. Ophthamic and neuroimaging associations in optic nerve hypoplasia/septo-optic-pituitary dysplasia. Can J Neurol Sci 2024;5:1-7. PMID 38178708
199: Sarnat HB. Cerebral dysgenesis. New York: Oxford Univ Pr, 1992:162-244.
200: Savasta S, Merli P, Introzzi F, et al. Agenesis of internal carotid artery and hypopituitarism: case report and review of the literature. J Clin Endcrinol Metab 2012;97:3414-20. PMID 22851490
201: Saylisoy S, Yorulmaz G. Coexistence of ectopic posterior ppituitary and sellar/suprasellar arachnoid cyst: a case report. Curr Med Imaging 2020;16(8):1055-7. PMID 32473002
202: Sbrogna JL, Barresi MJ, Karlstrom RO. Multiple roles for Hegdehog signaling in zebrafish pituitary development. Dev Biol 2003;254(1):19-35. PMID 12606279
203: Scala M, Accogli A, Alllegri AME, et al. Familial ROBO1 deletion associated with ectopic posterior pituitary, duplication of the pituitary stalk and anterior pituitary hypoplasia. J Pediatr Endocrinol Metab 2019;32(1):95-9. PMID 30530901
204: Schoenmakers N, Alatzoglou KS, Chatterjee VK, Dattani MT. Recent advances in central congenital hypothyroidism. J Endocrinol 2015;227(3):R51-71. PMID 26416826
205: Secco A, Allegri AE, di Lorgi N, et al. Posterior pituitary (PP) evaluation in patients with anterior pituitary defect associated with ectopic PP and septo-optic dysplasia. Eur J Endocrinol 2011;165:411-20. PMID 21750044
206: Shalata A, Lauhasurayotin S, Leibovitz Z, et al. Biallelic mutations in EXOC3L2 cause a novel syndrome that affects the brain, kidney and blood. J Med Genet 2018;56(5):340-6. PMID 30327448
207: Sharma H, Purwar N, Kumar A, et al. Pituitary hypoplasia is the best MRI predictor of the severity and type of growth hormone deficiency in children with congenital growth hormone deficiency. J Pediatr Endocrinol Metab 2021;34(7):851-8. PMID 33823100
208: Shimada A, Takagi M, Magashima Y, Miyai K, Hasegawa Y. A novel mutation in OTX2 causes combined pituitary hormone deficiency, bilateral microphthalmia, and agenesis of the left internal carotid artery. Horm Res Paediatr 2016;86(1):62-9. PMID 27299576
209: Shimo N, Yasuda T, Kitamura T, et al. Aniridia with a heterozygous PAX6 mutation in which the pituitary function was partially impaired. Intern Med 2014;53(1):39-42. PMID 24390526
210: Siebert JR, Cohen MM, Sulik KK, Shaw CM, Lemire RJ. Holoprosencephaly: an overview and atlas of cases. New York: Wiley-Liss, 1990.
211: Sills IN, Rapaport R, Robinson LP, et al. Familial Pallister-Hall syndrome: case report and hormonal evaluation. Am J Med Genet 1993;47(3):321-5. PMID 8135274
212: Silva TS, Faucz FR, Hernández-Ramírez LC, et al. Whole exome sequencing in patients with ectopic posterior pituitary. J Endocr Soc 2022;6(10):bvac116. PMID 36042976
213: Slavotinek AM. Eye development genes and known syndromes. Mol Genet Metab 2011;104:448-56. PMID 22005280
214: Soliman AT, Adel A, Soliman NA, Elalaily R, De Sanctis V. Pituitary deficiency following traumatic brain injury in early childhood: a review of the literature. Georgian Med News 2015;244-245:62-71. PMID 26177137
215: Spaziante R, de Divitiis E, Stella L, Cappabianca P, Genovese L. The empty sella. Surg Neurol 1981;16:418-26. PMID 7330763
216: Stagi S, Lapi E, Pantaleo M, et al. A SOX3 (Xq26.3-27.3) duplication in a boy with growth hormone deficiency, ocular dyspraxia, and intellectual disability: a long-term follow-up and literature review. Hormones (Athens) 2014;13(4):552-60. PMID 25402377
217: Stanhope R, Hindmarsh P, Kendall B, Brook CG. High resolution CT scanning of the pituitary gland in growth disorders. Acta Paediatr Scand 1986;75:779-86. PMID 3564946
218: Stefanovic V, Saraga Babić M, Wartiovaara J. Cell contacts in early human pituitary development. Acta Anat (Basel) 1993;148(4):169-75. PMID 8116328
219: Steiner MM, Boggs JD. Absence of pituitary gland, hypothyroidism, hypoadrenalism and hypogonadism in a 17-year-old dwarf. J Clin Endocrinol Metab 1965;25:1591-8. PMID 4284833
220: Stewart C, Castro-Magana M, Sherman J, Angulo M, Collipp PJ. Septo-optic dysplasia and median cleft face syndrome in a patient with isolated growth hormone deficiency and hyperprolactinemia. Am J Dis Child 1983;137:484-7. PMID 6846278
221: Sumathipala D, Strømme P, Gilissen C, et al. Sudden death in epilepsy and ectopic neurohypophysis in Joubert syndrome 23 diagnosed using SNVs/indels and structural variants pipelines on WSG data: a case report. BMC Med Genet 2020;21(1):96. PMID 32381069
222: Surtees R, Adams J, Price D, Clayton P, Shalet S. Association of adverse perinatal events with an empty sella turcica in children with growth hormone deficiency. Horm Res 1987;28:5-12. PMID 3447941
223: Taine L, Goizet C, Wen ZQ, et al. 18p monosomy with midline defects and a de novo satellite identified by FISH. Ann Genet 1997;40(3):158-63. PMID 9401105
224: Tajima T, Hattori T, Nakajima T, Okuhara K, Tsubaki J, Fujieda K. A novel missense mutation (P366T) of the LHX4 gene causes severe combined pituitary hormone deficiency with pituitary hypoplasia, ectopic posterior lobe and a poorly developed sella turcica. Endocr J 2007;54(4):637-41. PMID 17527005
225: Takanashi K, Suzuki Y, Noro A, et al. Three Japanese patients with congenital pituitary hormone deficiency and ophthalmological anomalies. Pediatr Rep 2011;3(3):e20. PMID 22053264
226: Tekiner H, Acer N, Kelestimur F. Sella turcica: an anatomical, endocrinological, and historical perspective. Pituitary 2015;18(4):575-8. PMID 25307180
227: Teller WM. Genetic disorders of the anterior pituitary gland. Prog Clin Biol Res 1985;200:91-102. PMID 3001777
228: Thakur M, Taha D, Misra VK. A case of congenital hypopituitarism associated with a 1p31 microdeletion: a possible role for LEPR and JAK. J Endocr Soc 2017;1(4):278-82. PMID 29264484
229: Thomas PQ, Dattani MT, Brickman JM, et al. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 2001;10(1):39-45. PMID 11136712
230: Toldo I, Calderone M, Sarton S, et al. Bilateral perisylvian polymicrogyria with cerebellar hypoplasia and ectopic neurohypophysis. J Child Neurol 2011;26(3):361-5. PMID 21273507
231: Trabacca A, De Rinaldis M, Gennaro L, Losito L. Septo-optic dysplasia-plus and dyskinetic cerebral palsy in a child. Neurol Sci 2012;33:159-63. PMID 21533562
232: Triulzi F, Scotti G, di Natale B, et al. Evidence of a congenital midline anomaly in pituitary dwarfs: a magnetic resonance imaging study in 101 patients. Pediatrics 1994;93(3):409-16. PMID 8115199
233: Uday S, Shaw N, Krone R, Kirk J. Hypopituitarism in children with cerebral palsy. Arch Dis Child 2017;102(6):559-61. PMID 27789461
234: Valdes-Socin H, Rubio-Almanza M, Tomé Fernández-Ladreda M, et al. Reproduction, smell, and neurodevelopmental disorders: genetic defects in different hypogonadotropic hypogonadal syndromes. Front Endocrinol (Lausanne) 2014;5:109. PMID 25071724
235: van der Linden AS, van Es HW. Pituitary stalk transection syndrome with ectopic posterior pituitary gland. Radiology 2007;243(2):594-7. PMID 17456881
236: Voutetakis A. Pituitary stalk interruption syndrome. Handb Clin Neurol 2021;181:9-27. PMID 34238482
237: Wadams HD, Gupta N, Novotny P, Tebben PJ. Onset of pituitary hormone deficiencies in optic nerve hypoplasia: a temporal trend analysis of 32 children at Mayo Clinic. J Pediatr Endocrinol Metab 2020;33(1):139-45. PMID 31811804
238: Waelchi R, Williams J, Cole T, et al. Growth and hormonal profiling in children with congenital melanocytic naevi. Br J Dermatol 2015;173(6):1471-8. PMID 26286459
239: Wang Q, Hu Y, Li G, Sun X. Pituitary stalk interruption syndrome in 59 children: the value of MRI in assessment of pituitary functions. Eur J Paediatr 2014;173(5):589-95. PMID 24257915
240: Wang W, Lufkin T. The murine Otp homeobox gene plays an essential role in the specification of neuronal cell lineages in the developing hypothalamus. Devel Biol 2000;227(2):432-9. PMID 11071765
241: Wit JM, Oostdijk W, Losekoot M, et al. Mechanisms in endocrinology: novel genetic causes of short stature. Eur J Endocrinol 2016;174(4):R145-73. PMID 26578640
242: Webb EA, AlMutair A, Kelberman D, et al. ARNT2 mutation causes hypopituitarism, post-natal microcephaly, visual and renal anomalies. Brain 2013;136(Pt 10):3096-105. PMID 24022475
243: Westphal H. Genes that fashion the pituitary gland. Mol and Cell Endocr 2002;197(1-2):45-6. PMID 12431794
244: Wunn R, Fellner CM, Fellner FA. Ectopic neurohypophysis with infundibular aplasia [Article in German]. Rofo 2016;188(2):205-6. PMID 26327675
245: Xu C, Zhang X, Dong L, Zhu B, Xin T. MRI features of growth hormone deficiency in children with short stature caused by pituitary lesions. Exp Ther Med 2017;13(6):3474-8. PMID 28587427
246: Yan CY, Wu FY, Sun F, et al. The isl2a transcription factor regulates pituitary development in zebrafish. Front Endorcrinol (Lausanne) 2023;14:920548. PMID 36824359
247: Yang A, Kim J, Cho SY, Lee JE, Kim HJ, Jin DK. A case of de novo 18p deletion syndrome with panhypopituitarism. Ann Pediatr Endocrinol Metab 2019;24(1):60-3. PMID 30943682
248: Yao Y, Liu Y, Wang L, et al. Clinical characteristics and management of growth hormone excess in patients with McCune-Albright syndrome. Eur J Endocrinol 2017;176(3):295-303. PMID 28007843
249: Ybarra M, Hafiz R, Robinson ME, von Oettingen JE, Bui H, Saint-Martin C. A new imaging entity consistent with partial ectopic posterior pituitary gland: report of six cases. Pediatr Radiol 2020;50(1):107-15. PMID 31468085
250: Yekeler E, Ozmen M, Genchellae H, Dursun M, Acunas G. Congenital bilateral perisylvian syndrome with pituitary hypoplasia and ectopic neurohypophysis. Pediatr Radiol 2004;34(11):1221-9. PMID 15168097
251: York D. Magnetic Resonance Imaging of CNS Diseases. St. Louis: Mosby, 2002.
252: Zhang DL, Blair MP, Zeid JL, Basith SST, Shapiro MJ. FEVR phenotype associated with septo-optic dysplasia. Ophthalmic Genet 2019;40(5):449-52. PMID 31755341
253: Zhang W, Qian F, Lu G, et al. Pituitary stalk interruption syndrome: a rare case report and literature review. Medicine (Baltimore) 2020;99(50):e23266. PMID 33327247
254: Ziad A, Khan Q, Farooq H, Rehman A, Siddique K. Pituitary stalk interruption syndrome: a case report. Cureus 2022;14(10):e30218. PMID 36381694
255: Zoric L, Nikolic S, Stojcic M, Zoric D, Jakovljevic S. Septo-optic dysplasia plus: a case report. BMC Res Notes 2014;7:191. PMID 24678945
256: Zucchini S, Ambrosetto P, Carla G, Tani G, Franzoni E, Cacciari E. Primary empty sella: differences and similarities between children and adults. Acta Pediatr 1995;84(12):1382-5. PMID 8645956
257: Zucchini S, Mazzanti L, Ambrosetto P, Salardi S, Cacciari E. Unusual magnetic resonance imaging findings of the sellar region in subjects with hypopituitarism: report of 4 cases. J Pediatr Endocrin Metabol 1998;11:35-44. PMID 9642627

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Harvey B Sarnat MS MD FRCPC

Dr. Sarnat of the University of Calgary has no relevant financial relationships to disclose.
See Profile

Former Authors

Inger Kjaer DDS
Troels W Kjaer MD PhD

Patient Profile

Age range of presentation: 0 month to 65+ years
Sex preponderance: male=female
Heredity: heredity may be a factor
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Pituitary aplasia, dysplasia, and ectopic neurohypophysis

Associated Disorders

Anencephaly
CHARGE syndrome
Cleft lip and palate
Duplication of pituitary stalk
Ectopic neurohypophysis
- Empty sella syndrome
- Holoprosencephaly
- Hypertelorism
- Midfacial anomalies
- Myelomeningocele
- Pallister-Hall syndrome
- Pituitary agenesis
- Pituitary aplasia
- Pituitary dysplasia
- Pituitary ectopia
- Pituitary hypoplasia
- Rathke cleft cyst
- Rachischisis
- Rieger syndrome
- Rubinstein-Taybi syndrome
- Septo-optic dysplasia
- Solitary maxillary central incisor
- Spina bifida

Differential Diagnosis

myxedema
Laron syndrome
Addison disease
ketotic hypoglycemia
empty sella syndrome

Also Relevant

Cerebellar hypoplasia, dysplasia, and enlargement
Holoprosencephaly
Hypopituitarism
Oral-facial-digital syndromes
Pituitary adenoma
- Pituitary apoplexy
- Septo-optic-pituitary dysplasia complex

Pituitary aplasia dysplasia and ectopic neurohypophysis …

Pituitary aplasia, dysplasia, and ectopic neurohypophysis

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Biological basis

Etiology and pathogenesis

Clinical vignette.

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Outcomes

Special considerations

Anesthesia

Media

References

Contributors

Author

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

X-linked hydrocephalus (L1 syndrome)

Cerebro-oculo-facio-skeletal syndrome

Schizencephaly

Fetal anticonvulsant syndrome

Rhombencephalosynapsis

Malformations of the brain

Von Hippel-Lindau disease

Vein of Galen malformations

Pituitary aplasia, dysplasia, and ectopic neurohypophysis

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Biological basis

Etiology and pathogenesis

Clinical vignette.

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Outcomes

Special considerations

Anesthesia

Media

References

Contributors

Author

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

X-linked hydrocephalus (L1 syndrome)

Cerebro-oculo-facio-skeletal syndrome

Schizencephaly

Fetal anticonvulsant syndrome

Rhombencephalosynapsis

Malformations of the brain

Von Hippel-Lindau disease

Vein of Galen malformations

This is an article preview.
Start a Free Account
to access the full version.